BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang YZ, Li YY. Inflammatory bowel disease: Pathogenesis. World J Gastroenterol 2014; 20(1): 91-99 [PMID: 24415861 DOI: 10.3748/wjg.v20.i1.91] [Cited by in CrossRef: 441] [Cited by in F6Publishing: 389] [Article Influence: 55.1] [Reference Citation Analysis]
Number Citing Articles
1 Wilson R, Gundamaraju R, Vemuri R, Angelucci C, Geraghty D, Gueven N, Eri RD. Identification of Key Pro-Survival Proteins in Isolated Colonic Goblet Cells of Winnie, a Murine Model of Spontaneous Colitis. Inflamm Bowel Dis 2020;26:80-92. [PMID: 31504521 DOI: 10.1093/ibd/izz179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bunte K, Beikler T. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int J Mol Sci. 2019;20. [PMID: 31295952 DOI: 10.3390/ijms20143394] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 24.7] [Reference Citation Analysis]
3 Morvaridi M, Jafarirad S, Seyedian SS, Alavinejad P, Cheraghian B. The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis. Eur J Clin Nutr 2020;74:891-9. [PMID: 31901082 DOI: 10.1038/s41430-019-0549-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
4 Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal Barrier in Human Health and Disease. Int J Environ Res Public Health 2021;18:12836. [PMID: 34886561 DOI: 10.3390/ijerph182312836] [Reference Citation Analysis]
5 Nemati S, Teimourian S, Tabrizi M, Najafi M, Dara N, Imanzadeh F, Ahmadi M, Aghdam MK, Tavassoli M, Rohani P, Madani SR, de Boer M, Kuijpers TW, Roos D. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children. Eur J Med Genet 2017;60:643-9. [PMID: 28864178 DOI: 10.1016/j.ejmg.2017.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fotschki B, Jurgonski A, Fotschki J, Majewski M, Ognik K, Juskiewicz J. Dietary Chicory Inulin-Rich Meal Exerts Greater Healing Effects than Fructooligosaccharide Preparation in Rats with Trinitrobenzenesulfonic Acid-Induced Necrotic Colitis. Pol J Food Nutr Sci 2019;69:147-55. [DOI: 10.31883/pjfns-2019-0013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Tsai MC, Lin HC, Lee CZ. A case-control study of the association between ulcerative colitis and hyperthyroidism in an Asian population. Clin Endocrinol (Oxf) 2017;86:825-9. [PMID: 28316075 DOI: 10.1111/cen.13332] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Nematgorgani S, Agah S, Shidfar F, Gohari M, Faghihi A. Effects of Urtica dioica leaf extract on inflammation, oxidative stress, ESR, blood cell count and quality of life in patients with inflammatory bowel disease. Journal of Herbal Medicine 2017;9:32-41. [DOI: 10.1016/j.hermed.2017.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
9 Wang RG. Progress and prospects of artificial intelligence in colonoscopy. Artif Intell Gastrointest Endosc 2021; 2(3): 63-70 [DOI: 10.37126/aige.v2.i3.63] [Reference Citation Analysis]
10 Zhang X, Ma L, Zhang C, Hou B, Zhou Y, Yu S. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterol Hepatol 2020:S0210-5705(20)30405-2. [PMID: 33317921 DOI: 10.1016/j.gastrohep.2020.10.008] [Reference Citation Analysis]
11 Milajerdi A, Abbasi F, Esmaillzadeh A. A systematic review and meta-analysis of prospective studies on obesity and risk of inflammatory bowel disease. Nutr Rev 2021:nuab028. [PMID: 34157115 DOI: 10.1093/nutrit/nuab028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Sahu KK, Minz S, Kaurav M, Pandey RS. Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis. Artif Cells Nanomed Biotechnol 2016;44:642-53. [PMID: 25379956 DOI: 10.3109/21691401.2014.975239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 De Martinis M, Allegra A, Sirufo MM, Tonacci A, Pioggia G, Raggiunti M, Ginaldi L, Gangemi S. Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review. Int J Mol Sci 2021;22:8855. [PMID: 34445560 DOI: 10.3390/ijms22168855] [Reference Citation Analysis]
14 Kye YJ, Lee SY, Kim HR, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Lactobacillus acidophilus PIN7 paraprobiotic supplementation ameliorates DSS-induced colitis through anti-inflammatory and immune regulatory effects. J Appl Microbiol 2021. [PMID: 34878713 DOI: 10.1111/jam.15406] [Reference Citation Analysis]
15 Du Y, Ding H, Vanarsa K, Soomro S, Baig S, Hicks J, Mohan C. Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability. Nutrients 2019;11:E1743. [PMID: 31362373 DOI: 10.3390/nu11081743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Yu Y, Yang W, Li Y, Cong Y. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:11-20. [PMID: 31560044 DOI: 10.1093/ibd/izz217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
17 Durymanov M, Kamaletdinova T, Lehmann SE, Reineke J. Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications. Journal of Controlled Release 2017;261:10-22. [DOI: 10.1016/j.jconrel.2017.06.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
18 Ye R, Huang J, Wang Z, Chen Y, Dong Y. Trace Element Selenium Effectively Alleviates Intestinal Diseases. Int J Mol Sci 2021;22:11708. [PMID: 34769138 DOI: 10.3390/ijms222111708] [Reference Citation Analysis]
19 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Thomas AS, Lin P. Ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2016;27:552-560. [PMID: 27585211 DOI: 10.1097/icu.0000000000000310] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Treese JS, Nolte I, Bach JP. Chronic enteropathy in dogs - retrospective case analysis and results of an owner survey. Tierarztl Prax Ausg K Kleintiere Heimtiere 2021;49:94-103. [PMID: 33902118 DOI: 10.1055/a-1354-0630] [Reference Citation Analysis]
22 Kuhn T, Koch M, Fuhrmann G. Probiomimetics—Novel Lactobacillus ‐Mimicking Microparticles Show Anti‐Inflammatory and Barrier‐Protecting Effects in Gastrointestinal Models. Small 2020;16:2003158. [DOI: 10.1002/smll.202003158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
23 Dziąbowska-Grabias K, Sztanke M, Zając P, Celejewski M, Kurek K, Szkutnicki S, Korga P, Bulikowski W, Sztanke K. Antioxidant Therapy in Inflammatory Bowel Diseases. Antioxidants (Basel) 2021;10:412. [PMID: 33803138 DOI: 10.3390/antiox10030412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Koon G, Atay O, Lapsia S. Gastrointestinal considerations related to youth sports and the young athlete. Transl Pediatr 2017;6:129-36. [PMID: 28795002 DOI: 10.21037/tp.2017.03.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Giménez-Bastida JA, González-Sarrías A, Espín JC, Schneider C. Inhibition of 5-Lipoxygenase-Derived Leukotrienes and Hemiketals as a Novel Anti-Inflammatory Mechanism of Urolithins. Mol Nutr Food Res 2020;64:e2000129. [PMID: 32306507 DOI: 10.1002/mnfr.202000129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Lee G, Kammermeier J, Vora R, Mutalib M. Review of a paediatric inflammatory bowel disease service during the pandemic and the impact of the CNS role. Br J Nurs 2021;30:840-4. [PMID: 34288747 DOI: 10.12968/bjon.2021.30.14.840] [Reference Citation Analysis]
27 Chen LZ, Zhang XX, Liu MM, Wu J, Ma D, Diao LZ, Li Q, Huang YS, Zhang R, Ruan BF, Liu XH. Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis. J Med Chem 2021;64:13633-57. [PMID: 34506712 DOI: 10.1021/acs.jmedchem.1c01007] [Reference Citation Analysis]
28 Gurung P, Banskota S, Katila N, Gautam J, Kadayat TM, Choi D, Lee ES, Jeong TC, Kim J. Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling. European Journal of Pharmacology 2018;827:94-102. [DOI: 10.1016/j.ejphar.2018.03.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Wang X, Fan X, Deng H, Zhang X, Zhang K, Xu J, Li N, Han Q, Liu Z. Use of oral contraceptives and risk of ulcerative colitis – A systematic review and meta-analysis. Pharmacological Research 2019;139:367-74. [DOI: 10.1016/j.phrs.2018.11.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
30 Yavne Y, Tiosano S, Ben-ami D, Watad A, Guy A, Comaneshter D, Cohen AD, Amital H. Giant cell arteritis and inflammatory bowel disease – Is there a connection? Results from a population-based study. Autoimmunity Reviews 2018;17:1134-7. [DOI: 10.1016/j.autrev.2018.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
31 Jeyakumar T, Fodil N, Van Der Kraak L, Meunier C, Cayrol R, McGregor K, Langlais D, Greenwood CMT, Beauchemin N, Gros P. Inactivation of Interferon Regulatory Factor 1 Causes Susceptibility to Colitis-Associated Colorectal Cancer. Sci Rep 2019;9:18897. [PMID: 31827213 DOI: 10.1038/s41598-019-55378-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chandan JS, Thomas T. The impact of inflammatory bowel disease on oral health. Br Dent J 2017;222:549-53. [PMID: 28387295 DOI: 10.1038/sj.bdj.2017.318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Somani S, Zambad S, Modi K. Mangiferin attenuates DSS colitis in mice: Molecular docking and in vivo approach. Chem Biol Interact 2016;253:18-26. [PMID: 27125760 DOI: 10.1016/j.cbi.2016.04.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
34 Huo LL, Sun ZR. MiR-128-3p alleviates TNBS-induced colitis through inactivating TRAF6/NF-κB signaling pathway in rats. Kaohsiung J Med Sci 2021. [PMID: 34042286 DOI: 10.1002/kjm2.12397] [Reference Citation Analysis]
35 Yashiro M. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Dig Dis Sci. 2015;60:2251-2263. [PMID: 25840920 DOI: 10.1007/s10620-015-3646-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
36 Nordström EA, Teixeira C, Montelius C, Jeppsson B, Larsson N. Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. Benef Microbes 2021;:1-26. [PMID: 34365915 DOI: 10.3920/BM2020.0191] [Reference Citation Analysis]
37 Tsai YW, Fu SH, Dong JL, Chien MW, Liu YW, Hsu CY, Sytwu HK. Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E9564. [PMID: 33334069 DOI: 10.3390/ijms21249564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Tejeda Taveras N, Rivera Martinez A, Kumar R, Jamil A, Kumar B. Pulmonary Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e14216. [PMID: 33948406 DOI: 10.7759/cureus.14216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Yu X, Yang G, Jiang H, Lin S, Liu Y, Zhang X, Zeng H, Su Z, Huang S, Shen L, Zhang X. Patchouli oil ameliorates acute colitis: A targeted metabolite analysis of 2,4,6-trinitrobenzenesulfonic acid-induced rats. Exp Ther Med 2017;14:1184-92. [PMID: 28810577 DOI: 10.3892/etm.2017.4577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
40 Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, Enyati N, Pasia G, Maesincee D, Ocon V, Abdulridha M, Longo VD. Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep 2019;26:2704-2719.e6. [PMID: 30840892 DOI: 10.1016/j.celrep.2019.02.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 33.0] [Reference Citation Analysis]
41 Sales-Campos H, Basso PJ, Alves VB, Fonseca MT, Bonfá G, Nardini V, Cardoso CR. Classical and recent advances in the treatment of inflammatory bowel diseases. Braz J Med Biol Res. 2015;48:96-107. [PMID: 25466162 DOI: 10.1590/1414-431x20143774] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
42 Wu B, Qiang L, Zhang Y, Fu Y, Zhao M, Lei Z, Lu Z, Wei YG, Dai H, Ge Y, Liu M, Zhou X, Peng Z, Li H, Cui CP, Wang J, Zheng H, Liu CH, Zhang L. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol 2021. [PMID: 34876703 DOI: 10.1038/s41423-021-00810-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jung DH, Yong JH, Hwang W, Yoon MY, Yoon SS. An efficient system for intestinal on-site butyrate production using novel microbiome-derived esterases. J Biol Eng 2021;15:9. [PMID: 33676548 DOI: 10.1186/s13036-021-00259-4] [Reference Citation Analysis]
44 Zhao J, Lu Q, Liu Y, Shi Z, Hu L, Zeng Z, Tu Y, Xiao Z, Xu Q. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies. J Immunol Res 2021;2021:8816041. [PMID: 33553436 DOI: 10.1155/2021/8816041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ono K, Nimura S, Hideshima Y, Nabeshima K, Nakashima M. Orally administered sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice. Exp Ther Med 2017;14:5485-90. [PMID: 29285080 DOI: 10.3892/etm.2017.5251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Heidarian F, Alebouyeh M, Shahrokh S, Balaii H, Zali MR. Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction. Curr Res Transl Med 2019;67:41-50. [PMID: 30685379 DOI: 10.1016/j.retram.2019.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
47 Kochhar G, Lashner B. Utility of Biomarkers in the Management of Inflammatory Bowel Disease. Curr Treat Options Gastroenterol 2017;15:105-15. [PMID: 28138859 DOI: 10.1007/s11938-017-0129-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
48 Luo X, Yue B, Yu Z, Ren Y, Zhang J, Ren J, Wang Z, Dou W. Obacunone Protects Against Ulcerative Colitis in Mice by Modulating Gut Microbiota, Attenuating TLR4/NF-κB Signaling Cascades, and Improving Disrupted Epithelial Barriers. Front Microbiol 2020;11:497. [PMID: 32296403 DOI: 10.3389/fmicb.2020.00497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
49 Chandraiah SB, Ghosh S, Saha I, More SS, Annappa GS, Maiti AK. Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis. 3 Biotech 2021;11:199. [PMID: 33927989 DOI: 10.1007/s13205-021-02755-2] [Reference Citation Analysis]
50 Ahmed A, Schmidt C, Brunner T. Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape. Front Immunol 2019;10:1438. [PMID: 31316505 DOI: 10.3389/fimmu.2019.01438] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
51 Herman SM, Zaborniak K, Bernstein CN. Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind? Inflamm Bowel Dis 2021:izab183. [PMID: 34473278 DOI: 10.1093/ibd/izab183] [Reference Citation Analysis]
52 Formiga RO, Alves Júnior EB, Vasconcelos RC, Guerra GCB, Antunes de Araújo A, Carvalho TG, Garcia VB, de Araújo Junior RF, Gadelha FAAF, Vieira GC, Sobral MV, Barbosa Filho JM, Spiller F, Batista LM. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. Int J Mol Sci 2020;21:E5870. [PMID: 32824269 DOI: 10.3390/ijms21165870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
53 She YY, Kong XB, Ge YP, Liu ZY, Chen JY, Jiang JW, Jiang HB, Fang SL. Periodontitis and inflammatory bowel disease: a meta-analysis. BMC Oral Health 2020;20:67. [PMID: 32164696 DOI: 10.1186/s12903-020-1053-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
54 Mazieiro R, Frizon RR, Barbalho SM, Goulart RA. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? J Med Food 2018;21:1077-85. [PMID: 29957091 DOI: 10.1089/jmf.2017.0146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
55 Swaminath A, Berlin EP, Cheifetz A, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information. Inflamm Bowel Dis 2019;25:427-35. [PMID: 30358848 DOI: 10.1093/ibd/izy319] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
56 Xu D, Xu H, Zhang Y, Wang M, Chen W, Gao R. MDAKRLS: Predicting human microbe-disease association based on Kronecker regularized least squares and similarities. J Transl Med 2021;19:66. [PMID: 33579301 DOI: 10.1186/s12967-021-02732-6] [Reference Citation Analysis]
57 Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019;10:1386. [PMID: 31275322 DOI: 10.3389/fimmu.2019.01386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
58 Cota D, Mishra S, Shengule S. Beneficial role of Terminalia arjuna hydro-alcoholic extract in colitis and its possible mechanism. Journal of Ethnopharmacology 2019;230:117-25. [DOI: 10.1016/j.jep.2018.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
59 Dowdell AS, Colgan SP. Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD). Pharmaceuticals (Basel) 2021;14:708. [PMID: 34451805 DOI: 10.3390/ph14080708] [Reference Citation Analysis]
60 Salem M, Ammitzboell M, Nys K, Seidelin JB, Nielsen OH. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy. 2015;11:585-594. [PMID: 25906181 DOI: 10.1080/15548627.2015.1017187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Danese S, Grisham M, Hodge J, Telliez JB. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 2016;310:G155-G162. [PMID: 26608188 DOI: 10.1152/ajpgi.00311.2015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
62 Luo C, Zou L, Sun H, Peng J, Gao C, Bao L, Ji R, Jin Y, Sun S. A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases. Front Pharmacol 2020;11:153. [PMID: 32184728 DOI: 10.3389/fphar.2020.00153] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
63 Senhaji N, Serrano A, Badre W, Serbati N, Karkouri M, Zaid Y, Nadifi S, Martin J. Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort. Genes Immun. 2016;17:60-65. [PMID: 26632999 DOI: 10.1038/gene.2015.52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
64 Macías-Barragán J, Montoya-Buelna M, Enciso-Vargas M, Alvarado-Ruíz L, Oceguera-Contreras E, Guerra-Renteria AS, Graciano-Machuca O. Assessment of the Relationship between Clinical Variants of Psoriasis and Killer Immunoglobulin-like Receptor (KIR) Genes: A Systematic Review with Meta-analysis. Immunol Invest 2020;:1-16. [PMID: 33115277 DOI: 10.1080/08820139.2020.1840582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Abraham BP, Ahmed T, Ali T. Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches. In: Greenwood-van Meerveld B, editor. Gastrointestinal Pharmacology. Cham: Springer International Publishing; 2017. pp. 115-46. [DOI: 10.1007/164_2016_122] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
66 Russo M, Miraglia C, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Approach to gastroenterological diseases in primary care. Acta Biomed 2018;89:5-11. [PMID: 30561411 DOI: 10.23750/abm.v89i8-S.7973] [Reference Citation Analysis]
67 Jordi SBU, Botte F, Lang BM, Greuter T, Krupka N, Auschra B, Schreiner P, Sulz MC, Biedermann L, von Känel R, Rogler G, Begré S, Misselwitz B; Swiss IBD cohort study group. Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:53-67. [PMID: 33975385 DOI: 10.1111/apt.16365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015;8:29-44. [PMID: 26078592 DOI: 10.4137/cgast.s20612] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
69 Rizzetto L, De Filippo C, Cavalieri D. Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease: Highlights. Eur J Immunol 2014;44:3166-81. [DOI: 10.1002/eji.201344403] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
70 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
71 Daguet D, Pinheiro I, Verhelst A, Possemiers S, Marzorati M. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the Simulator of the Human Intestinal Microbial Ecosystem. Journal of Functional Foods 2016;20:369-79. [DOI: 10.1016/j.jff.2015.11.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
72 Leber A, Hontecillas R, Tubau-Juni N, Bassaganya-Riera J. Translating nutritional immunology into drug development for inflammatory bowel disease. Curr Opin Gastroenterol 2016;32:443-9. [PMID: 27673381 DOI: 10.1097/MOG.0000000000000317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Zang KH, Rao Z, Zhang GQ, Qin HY. Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin. Indian J Pharmacol 2015;47:632-7. [PMID: 26729955 DOI: 10.4103/0253-7613.169584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
74 Chandwe K, Kelly P. Colostrum Therapy for Human Gastrointestinal Health and Disease. Nutrients 2021;13:1956. [PMID: 34200282 DOI: 10.3390/nu13061956] [Reference Citation Analysis]
75 Haep L, Britzen-Laurent N, Weber TG, Naschberger E, Schaefer A, Kremmer E, Foersch S, Vieth M, Scheuer W, Wirtz S. Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice. Inflamm Bowel Dis. 2015;21:2360-2371. [PMID: 26164664 DOI: 10.1097/mib.0000000000000490] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
76 Fernández-clotet A, Castro-poceiro J, Panés J. Tofacitinib for the treatment of ulcerative colitis. Expert Review of Clinical Immunology 2018;14:881-92. [DOI: 10.1080/1744666x.2018.1532291] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
77 Bardenbacher M, Ruder B, Britzen-Laurent N, Schmid B, Waldner M, Naschberger E, Scharl M, Müller W, Günther C, Becker C, Stürzl M, Tripal P. Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids. Stem Cell Res 2019;35:101383. [PMID: 30776676 DOI: 10.1016/j.scr.2019.101383] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
78 Larrosa Pardo F, Bondesson E, Schelin MEC, Jöud A. A diagnosis of rheumatoid arthritis, endometriosis or IBD is associated with later onset of fibromyalgia and chronic widespread pain. Eur J Pain 2019;23:1563-73. [PMID: 31131959 DOI: 10.1002/ejp.1432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
79 Ashton JJ, Latham K, Beattie RM, Ennis S. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:885-900. [PMID: 31518029 DOI: 10.1111/apt.15485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Marius M, Amadou D, Donatien AA, Gilbert A, William YN, Rauf K, Arif M, Adeline FYS, Saint NI, Dar H, Rehman NU, Ahmad I. In Vitro Antioxidant, Anti-inflammatory, and In Vivo Anticolitis Effects of Combretin A and Combretin B on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. Gastroenterol Res Pract 2020;2020:4253174. [PMID: 33204254 DOI: 10.1155/2020/4253174] [Reference Citation Analysis]
81 Berger AA, Liu Y, Jin K, Kaneb A, Welschmeyer A, Cornett EM, Kaye AD, Imani F, Khademi SH, Varrassi G, Viswanath O, Urits I. Efficacy of Acupuncture in the Treatment of Chronic Abdominal Pain. Anesth Pain Med 2021;11:e113027. [PMID: 34336622 DOI: 10.5812/aapm.113027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
82 Xu X, Huang J, Ocansey DKW, Xia Y, Zhao Z, Xu Z, Yan Y, Zhang X, Mao F. The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. J Inflamm Res 2021;14:3289-306. [PMID: 34290515 DOI: 10.2147/JIR.S320449] [Reference Citation Analysis]
83 Holmes EA, Rodney Harris RM, Lucas RM. Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochem Photobiol 2019;95:105-18. [PMID: 30155900 DOI: 10.1111/php.13007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
84 Alrefai D, Jones J, El-Matary W, Whiting SJ, Aljebreen A, Mirhosseini N, Vatanparast H. The Association of Vitamin D Status with Disease Activity in a Cohort of Crohn's Disease Patients in Canada. Nutrients 2017;9:E1112. [PMID: 29023388 DOI: 10.3390/nu9101112] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
85 Szakács Z, Csiszár B, Kenyeres P, Sarlós P, Erőss B, Hussain A, Nagy Á, Kőszegi B, Veczák I, Farkas N, Bódis E, Márta K, Szentesi A, Tőkés-Füzesi M, Berki T, Vincze Á, Tóth K, Hegyi P, Bajor J. Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol. BMJ Open 2019;9:e026315. [PMID: 30904871 DOI: 10.1136/bmjopen-2018-026315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Chen Y, Liu H, Zhang Q, Luo Y, Wu L, Zhong Y, Tang Z, Pu Y, Lu C, Yin G, Xie Q. Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Front Pharmacol 2021;12:735194. [PMID: 34880751 DOI: 10.3389/fphar.2021.735194] [Reference Citation Analysis]
87 Bhoola PH, Shtofmakher G, Bahri A, Patel AA, Barlizo SR, Trepal M. Pedal Gangrenous Changes in the Digits of an Adolescent With Ulcerative Colitis: A Case Report. J Foot Ankle Surg. 2014; Aug 16. [Epub ahead of print]. [PMID: 25135104 DOI: 10.1053/j.jfas.2014.06.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Castle R, Bushell WC, Mills PJ, Williams MA, Chopra D, Rindfleisch JA. Global Correlations Between Chronic Inflammation and Violent Incidents: Potential Behavioral Consequences of Inflammatory Illnesses Across Socio-Demographic Levels. Int J Gen Med 2021;14:6677-91. [PMID: 34675629 DOI: 10.2147/IJGM.S324367] [Reference Citation Analysis]
89 Ashton JJ, Green Z, Kolimarala V, Beattie RM. Inflammatory bowel disease: long-term therapeutic challenges. Expert Rev Gastroenterol Hepatol 2019;13:1049-63. [PMID: 31657969 DOI: 10.1080/17474124.2019.1685872] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Sang L, Chang B, Zhu J, Yang F, Li Y, Jiang X, Sun X, Lu C, Wang D. Dextran sulfate sodium-induced acute experimental colitis in C57BL/6 mice is mitigated by selenium. Int Immunopharmacol 2016;39:359-68. [PMID: 27533281 DOI: 10.1016/j.intimp.2016.07.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
91 Hashash JG, Hartman DJ. Inflammatory cells implicated in neoplasia development in idiopathic inflammatory bowel disease. Cell Immunol 2019;343:103720. [PMID: 29221690 DOI: 10.1016/j.cellimm.2017.11.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 He X, Wang WZ, Zhao CH, Sun JS, Wang LH. Significance of expression of adiponectin in patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(12): 1999-2002 [DOI: 10.11569/wcjd.v23.i12.1999] [Reference Citation Analysis]
93 Pereira MS, Munerato MC. Oral Manifestations of Inflammatory Bowel Diseases: Two Case Reports. Clin Med Res 2016;14:46-52. [PMID: 26864508 DOI: 10.3121/cmr.2015.1307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Zhang J, Zhao Y, Hou T, Zeng H, Kalambhe D, Wang B, Shen X, Huang Y. Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 2020;320:363-80. [DOI: 10.1016/j.jconrel.2020.01.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
95 Kang ZP, Wang MX, Wu TT, Liu DY, Wang HY, Long J, Zhao HM, Zhong YB. Curcumin Alleviated Dextran Sulfate Sodium-Induced Colitis by Regulating M1/M2 Macrophage Polarization and TLRs Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:3334994. [PMID: 34567209 DOI: 10.1155/2021/3334994] [Reference Citation Analysis]
96 Jordi SBU, Lang BM, Auschra B, von Känel R, Biedermann L, Greuter T, Schreiner P, Rogler G, Krupka N, Sulz MC, Misselwitz B, Begré S; Swiss IBD Cohort Study Group . Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab136. [PMID: 34096587 DOI: 10.1093/ibd/izab136] [Reference Citation Analysis]
97 Gao X, Fan W, Tan L, Shi Y, Ding C, Liu S, Miao Y, Luo Y, Shi X, DeSaeger S, Song S. Soy isoflavones ameliorate experimental colitis by targeting ERα/NLRP3 inflammasome pathways. J Nutr Biochem 2020;83:108438. [PMID: 32563803 DOI: 10.1016/j.jnutbio.2020.108438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Jin X, Chen D, Zheng RH, Zhang H, Chen YP, Xiang Z. miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism. World J Gastroenterol 2017; 23(1): 76-86 [PMID: 28104982 DOI: 10.3748/wjg.v23.i1.76] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
99 Ye C, Yano H, Workman CJ, Vignali DAA. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases. J Interferon Cytokine Res 2021;41:391-406. [PMID: 34788131 DOI: 10.1089/jir.2021.0147] [Reference Citation Analysis]
100 Morsy Y, Brillant N, Franc Y, Scharl M, Wawrzyniak M, On Behalf Of The Swiss Ibd Cohort Study Group. Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease. Cells 2021;10:3589. [PMID: 34944097 DOI: 10.3390/cells10123589] [Reference Citation Analysis]
101 Shmuel-Galia L, Aychek T, Fink A, Porat Z, Zarmi B, Bernshtein B, Brenner O, Jung S, Shai Y. Neutralization of pro-inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis. EMBO J 2016;35:685-98. [PMID: 26884587 DOI: 10.15252/embj.201592649] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
102 Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019; 25(33): 4796-4804 [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
103 Wottawa F, Bordoni D, Baran N, Rosenstiel P, Aden K. The role of cGAS/STING in intestinal immunity. Eur J Immunol 2021;51:785-97. [PMID: 33577080 DOI: 10.1002/eji.202048777] [Reference Citation Analysis]
104 Florholmen JR, Johnsen KM, Meyer R, Olsen T, Moe ØK, Tandberg P, Gundersen MD, Kvamme JM, Johnsen K, Løitegård T, Raschpichler G, Vold C, Sørbye SW, Goll R. Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis. BMC Gastroenterol 2020;20:321. [PMID: 33008302 DOI: 10.1186/s12876-020-01447-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Gong Z, Zhao S, Zhou J, Yan J, Wang L, Du X, Li H, Chen Y, Cai W, Wu J. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production. Mol Immunol 2018;104:11-9. [PMID: 30396035 DOI: 10.1016/j.molimm.2018.09.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 12.3] [Reference Citation Analysis]
106 Chakravarti D, Lee R, Multani AS, Santoni A, Keith Z, Hsu WH, Chang K, Reyes L, Rashid A, Wu CJ, Li J, Zhang J, Shim HS, Chandra K, Deng P, Spring DJ, Nielsen OH, Riis LB, Mayigegowda KK, Blutt SE, Zhang J, Younes M, DuPont A, Thirumurthi S, Vilar E, Estes MK, Colla S, Shroyer NF, DePinho RA. Telomere dysfunction instigates inflammation in inflammatory bowel disease. Proc Natl Acad Sci U S A 2021;118:e2024853118. [PMID: 34253611 DOI: 10.1073/pnas.2024853118] [Reference Citation Analysis]
107 Sienkiewicz M, Szymańska P, Fichna J. Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications. Adv Nutr 2021;12:533-45. [PMID: 33070186 DOI: 10.1093/advances/nmaa120] [Reference Citation Analysis]
108 Widbom L, Ekblom K, Karling P, Hultdin J. Patients developing inflammatory bowel disease have iron deficiency and lower plasma ferritin years before diagnosis: a nested case-control study. Eur J Gastroenterol Hepatol 2020;32:1147-53. [PMID: 32541236 DOI: 10.1097/MEG.0000000000001816] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Zhang W, Tyrrell H, Ding HT, Pulley J, Boruvka A, Erickson R, Abouhossein M, Ravanello R, Tang MT. Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Adv Ther 2021;38:2418-34. [PMID: 33778929 DOI: 10.1007/s12325-021-01661-6] [Reference Citation Analysis]
110 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
111 Hou S, Yang X, Tong Y, Yang Y, Chen Q, Wan B, Wei R, Wang Y, Zhang Y, Kong B, Huang J, Chen Y, Lu T, Hu Q, Du D. Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis. Eur J Med Chem 2021;211:113114. [PMID: 33360793 DOI: 10.1016/j.ejmech.2020.113114] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
113 Ju JK, Cho YN, Park KJ, Kwak HD, Jin HM, Park SY, Kim HS, Kee SJ, Park YW. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease. J Innate Immun 2020;12:422-34. [PMID: 32535589 DOI: 10.1159/000507931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
114 Zhang YJ, Wu Q. Sulforaphane protects intestinal epithelial cells against lipopolysaccharide-induced injury by activating the AMPK/SIRT1/PGC-1ɑ pathway. Bioengineered 2021;12:4349-60. [PMID: 34308769 DOI: 10.1080/21655979.2021.1952368] [Reference Citation Analysis]
115 Si XY, Merlin D, Xiao B. Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7718-7726 [PMID: 27678353 DOI: 10.3748/wjg.v22.i34.7718] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
116 Oh SJ, Seo Y, Ahn JS, Shin YY, Yang JW, Kim HK, Han J, Mishchenko NP, Fedoreyev SA, Stonik VA, Kim HS. Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells. Mar Drugs 2019;17:E622. [PMID: 31683521 DOI: 10.3390/md17110622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
117 Tomusiak-Plebanek A, Heczko P, Skowron B, Baranowska A, Okoń K, Thor PJ, Strus M. Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model. Drug Des Devel Ther 2018;12:3221-33. [PMID: 30319243 DOI: 10.2147/DDDT.S164559] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
118 Liu XK, Zhao HM, Wang HY, Ge W, Zhong YB, Long J, Liu DY. Regulatory Effect of Sishen Pill on Tfh Cells in Mice With Experimental Colitis. Front Physiol 2020;11:589. [PMID: 32581849 DOI: 10.3389/fphys.2020.00589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Cao F, Liu J, Sha B, Pan H. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy. CPD 2020;25:4893-913. [DOI: 10.2174/1381612825666191216154224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
120 Basar O, Dailey F, Dailey E, Tahan V, Daglilar E. Interferon-Induced Crohn's Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection. Cureus 2021;13:e15568. [PMID: 34277190 DOI: 10.7759/cureus.15568] [Reference Citation Analysis]
121 Cheru L, Saylor CF, Lo J. Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation. Curr Obes Rep 2019;8:165-74. [PMID: 30847735 DOI: 10.1007/s13679-019-00332-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
122 Nettleford SK, Prabhu KS. Selenium and Selenoproteins in Gut Inflammation-A Review. Antioxidants (Basel) 2018;7:E36. [PMID: 29494512 DOI: 10.3390/antiox7030036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
123 Zhou C, Wu XR, Liu HS, Liu XH, Liu GH, Zheng XB, Hu T, Liang ZX, He XW, Wu XJ, Smith LC, Zhang Y, Lan P. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner. J Crohns Colitis. 2020;14:654-668. [PMID: 31841595 DOI: 10.1093/ecco-jcc/jjz200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
124 Rosa A, Abrantes P, Sousa I, Francisco V, Santos P, Francisco D, Xavier JM, Oliveira SA. Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control. Inflamm Bowel Dis 2016;22:774-81. [PMID: 26926037 DOI: 10.1097/MIB.0000000000000694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
125 Astley DJ, Masters N, Kuballa A, Katouli M. Commonality of adherent-invasive Escherichia coli isolated from patients with extraintestinal infections, healthy individuals and the environment. Eur J Clin Microbiol Infect Dis 2021;40:181-92. [PMID: 33063232 DOI: 10.1007/s10096-020-04066-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Randall CW, Vizuete JA, Martinez N, Alvarez JJ, Garapati KV, Malakouti M, Taboada CM. From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease. Therap Adv Gastroenterol 2015;8:143-59. [PMID: 25949527 DOI: 10.1177/1756283X15576462] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
127 Pabari RM, Tambuwala MM, Lajczak-McGinley N, Aljabali A, Kirby BP, Keely S, Ramtoola Z. Novel polyurethane based particulate formulations of infliximab reduce inflammation in DSS induced murine model of colitis - A preliminary study. Int J Pharm 2021;604:120717. [PMID: 34015378 DOI: 10.1016/j.ijpharm.2021.120717] [Reference Citation Analysis]
128 Vernero M, De Blasio F, Ribaldone DG, Bugianesi E, Pellicano R, Saracco GM, Astegiano M, Caviglia GP. The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study. J Clin Med 2020;9:E3941. [PMID: 33291846 DOI: 10.3390/jcm9123941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Sange AH, Srinivas N, Sarnaik MK, Modi S, Pisipati Y, Vaidya S, Syed Gaggatur N, Sange I. Extra-Intestinal Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e17187. [PMID: 34548984 DOI: 10.7759/cureus.17187] [Reference Citation Analysis]
130 Liu J, Yu L, Mo N, Lan H, Zhang Y, Liu X, Wu Q. Supercritical Fluid Extract of Angelica sinensis and Zingiber officinale Roscoe Ameliorates TNBS-Induced Colitis in Rats. Int J Mol Sci 2019;20:E3816. [PMID: 31387229 DOI: 10.3390/ijms20153816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
131 Almási N, Török S, Dvorácskó S, Tömböly C, Csonka Á, Baráth Z, Murlasits Z, Valkusz Z, Pósa A, Varga C, Kupai K. Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway. Int J Mol Sci 2020;21:E4046. [PMID: 32516975 DOI: 10.3390/ijms21114046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Tadin Hadjina I, Zivkovic PM, Matetic A, Rusic D, Vilovic M, Bajo D, Puljiz Z, Tonkic A, Bozic J. Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep 2019;9:13740. [PMID: 31551482 DOI: 10.1038/s41598-019-50192-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
133 Kolios G. Bin1 Antibodies for IBD Therapy: Is Permeability the Answer BAR None? Dig Dis Sci 2016;61:330-1. [PMID: 26694171 DOI: 10.1007/s10620-015-3997-x] [Reference Citation Analysis]
134 Han Y, Zhao R, Xu F. Neutrophil-Based Delivery Systems for Nanotherapeutics. Small 2018;14:e1801674. [PMID: 30144279 DOI: 10.1002/smll.201801674] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
135 Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microbial Pathogenesis 2019;137:103774. [DOI: 10.1016/j.micpath.2019.103774] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
136 Estevinho MM, Afonso J, Rosa I, Lago P, Trindade E, Correia L, Dias CC, Magro F; GEDII [Portuguese IBD Group]. Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis. J Crohns Colitis 2018;12:1232-44. [PMID: 30010736 DOI: 10.1093/ecco-jcc/jjy100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
137 Song D, Lai L, Ran Z. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease. Front Immunol 2020;11:580467. [PMID: 33193381 DOI: 10.3389/fimmu.2020.580467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
138 Xu F, Cheng Y, Ruan G, Fan L, Tian Y, Xiao Z, Chen D, Wei Y. New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut-brain axis. Therap Adv Gastroenterol 2021;14:17562848211004469. [PMID: 33948112 DOI: 10.1177/17562848211004469] [Reference Citation Analysis]
139 Zhang JZ, Bao CH, Shi Z, Weng ZJ, Wang XM, Wu LY, Wu HG. Role of intestinal microbiota in pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4505-4513 [DOI: 10.11569/wcjd.v24.i33.4505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Veenstra JP, Vemu B, Tocmo R, Nauman MC, Johnson JJ. Pharmacokinetic Analysis of Carnosic Acid and Carnosol in Standardized Rosemary Extract and the Effect on the Disease Activity Index of DSS-Induced Colitis. Nutrients 2021;13:773. [PMID: 33673488 DOI: 10.3390/nu13030773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
141 Cao X, Cao L, Zhang W, Lu R, Bian JS, Nie X. Therapeutic potential of sulfur-containing natural products in inflammatory diseases. Pharmacol Ther 2020;216:107687. [PMID: 32966837 DOI: 10.1016/j.pharmthera.2020.107687] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Guadagnoli L, Mutlu EA, Doerfler B, Ibrahim A, Brenner D, Taft TH. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Qual Life Res 2019;28:2195-205. [PMID: 30900206 DOI: 10.1007/s11136-019-02170-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
143 Anka Idrissi D, Senhaji N, Aouiss A, Khalki L, Tijani Y, Zaid N, Marhoume FZ, Naya A, Oudghiri M, Kabine M, Zaid Y. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets. Arch Pharm Res 2021;44:117-32. [PMID: 33394309 DOI: 10.1007/s12272-020-01296-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
144 He X, Zhang QQ, Wang Z, Wang WZ, Wang LH. Chinese medicine enema for treatment of patients with mild to moderate ulcerative colitis: Therapeutic effect and regulatory effect on adiponectin. Shijie Huaren Xiaohua Zazhi 2015; 23(17): 2834-2838 [DOI: 10.11569/wcjd.v23.i17.2834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Geirnaert A, Calatayud M, Grootaert C, Laukens D, Devriese S, Smagghe G, De Vos M, Boon N, Van de Wiele T. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci Rep 2017;7:11450. [PMID: 28904372 DOI: 10.1038/s41598-017-11734-8] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 28.8] [Reference Citation Analysis]
146 Cristina Lopes do Carmo M, Mateus Martins I, Elisa Ramos Magalhães A, Roberto Maróstica Júnior M, Alves Macedo J. Passion fruit (Passiflora edulis) leaf aqueous extract ameliorates intestinal epithelial barrier dysfunction and reverts inflammatory parameters in Caco-2 cells monolayer. Food Res Int 2020;133:109162. [PMID: 32466926 DOI: 10.1016/j.foodres.2020.109162] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
147 Ulugöl S, Hering L, Manzini R, Montalban Arques A, Gottier C, Lang S, Scharl M, Spalinger MR. Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23. Inflamm Intest Dis 2019;4:14-26. [PMID: 31172009 DOI: 10.1159/000499157] [Reference Citation Analysis]
148 Lee YJ, Kim YH, Kim HW. Preconception Care Program for Women with Inflammatory Bowel Disease Using Intervention Mapping: A Protocol for Program Development. Int J Environ Res Public Health 2020;17:E9365. [PMID: 33327583 DOI: 10.3390/ijerph17249365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Jang HM, Kim JK, Joo MK, Shin YJ, Lee CK, Kim HJ, Kim DH. Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice. Sci Rep 2021;11:20406. [PMID: 34650107 DOI: 10.1038/s41598-021-00088-x] [Reference Citation Analysis]
151 Kikut J, Konecka N, Ziętek M, Szczuko M. Inflammatory Bowel Disease Etiology: Current Knowledge. Pteridines 2018;29:206-14. [DOI: 10.1515/pteridines-2018-0020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Zacharopoulou E, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Dig Liver Dis. 2017;49:1067-1072. [PMID: 28869157 DOI: 10.1016/j.dld.2017.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
153 Vong CT, Tseng HHL, Yao P, Yu H, Wang S, Zhong Z, Wang Y. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases. Drug Discov Today 2021;26:1394-408. [PMID: 33636340 DOI: 10.1016/j.drudis.2021.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 An HJ, Tizaoui K, Terrazzino S, Cargnin S, Lee KH, Nam SW, Kim JS, Yang JW, Lee JY, Smith L, Koyanagi A, Jacob L, Li H, Shin JI, Kronbichler A. Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review. Int J Mol Sci 2020;21:E5678. [PMID: 32784808 DOI: 10.3390/ijms21165678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
155 Andrade MER, Barros PAVD, Menta PLDR, Costa GMF, Miranda SEM, Leocádio PCL, Almeida-leite CMD, Generoso SDV, Leite JIA, Cardoso VN. Arginine supplementation reduces colonic injury, inflammation and oxidative stress of DSS-induced colitis in mice. Journal of Functional Foods 2019;52:360-9. [DOI: 10.1016/j.jff.2018.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Tertychnyi AS, Akhrieva KM, Zayratyants OV, Selivanova LS, Birg TM. Somatostatin receptor expression in the ileal mucosa of patients with inflammatory bowel disease. Arkh patol 2016;78:19. [DOI: 10.17116/patol201678119-24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
157 Cai Q, Wu L, Zhou Y. Experiences With Traditional Chinese Medicine Among Patients With Inflammatory Bowel Disease: A Qualitative Study. Gastroenterol Nurs 2020;43:135-45. [PMID: 32251215 DOI: 10.1097/SGA.0000000000000418] [Reference Citation Analysis]
158 Krawiec P, Pawłowska-Kamieniak A, Pac-Kożuchowska E. Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson. J Inflamm (Lond) 2021;18:13. [PMID: 33691712 DOI: 10.1186/s12950-021-00279-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Truffi M, Sevieri M, Morelli L, Monieri M, Mazzucchelli S, Sorrentino L, Allevi R, Bonizzi A, Zerbi P, Marchini B, Longhi E, Sampietro GM, Colombo F, Prosperi D, Colombo M, Corsi F. Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease. Int J Nanomedicine 2020;15:8537-52. [PMID: 33173291 DOI: 10.2147/IJN.S264513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Wang H, Zhou Y, Sun Q, Zhou C, Hu S, Lenahan C, Xu W, Deng Y, Li G, Tao S. Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment. Front Bioeng Biotechnol 2021;9:630352. [PMID: 33681167 DOI: 10.3389/fbioe.2021.630352] [Reference Citation Analysis]
161 Meng LL, Wu ZJ. Clinical utility of fecal neutrophil-derived biomarkers in evaluating activity of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2014; 22(35): 5473-5479 [DOI: 10.11569/wcjd.v22.i35.5473] [Reference Citation Analysis]
162 Zhang B, Xu Y, Liu S, Lv H, Hu Y, Wang Y, Li Z, Wang J, Ji X, Ma H, Wang X, Wang S. Dietary Supplementation of Foxtail Millet Ameliorates Colitis-Associated Colorectal Cancer in Mice via Activation of Gut Receptors and Suppression of the STAT3 Pathway. Nutrients 2020;12:E2367. [PMID: 32784751 DOI: 10.3390/nu12082367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Huang J, Chen T, Liu Y, Lyu L, Li X, Yue W. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)? Turk J Gastroenterol 2019;30:132-8. [PMID: 30429108 DOI: 10.5152/tjg.2018.17828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Kaplan M, Yuksel M, Ates I, Kilic ZM, Kilic H, Kuzu UB, Kayacetin E. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases? J Gastroenterol Hepatol 2016;31:1120-5. [PMID: 26642816 DOI: 10.1111/jgh.13254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
165 Hasanzadeh S, Read MI, Bland AR, Majeed M, Jamialahmadi T, Sahebkar A. Curcumin: an inflammasome silencer. Pharmacological Research 2020;159:104921. [DOI: 10.1016/j.phrs.2020.104921] [Cited by in Crossref: 50] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
166 Nong H, Huang X. Murine model of dextran sodium sulfate induced ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3245-3250 [DOI: 10.11569/wcjd.v22.i22.3245] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
167 Goyal N, Rana A, Ahlawat A, Bijjem KR, Kumar P. Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014;22:219-233. [PMID: 24906689 DOI: 10.1007/s10787-014-0207-y] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
168 Fuertes-Martín R, Correig X, Vallvé JC, Amigó N. Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment. J Clin Med 2020;9:E354. [PMID: 32012794 DOI: 10.3390/jcm9020354] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
169 Song R, Li Y, Hao W, Wang B, Yang L, Xu F. Identification and analysis of key genes associated with ulcerative colitis based on DNA microarray data. Medicine (Baltimore) 2018;97:e10658. [PMID: 29794741 DOI: 10.1097/MD.0000000000010658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
170 Wu Z, Pan D, Jiang M, Sang L, Chang B. Selenium-Enriched Lactobacillus acidophilus Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice by Regulating Inflammatory Cytokines and Intestinal Microbiota. Front Med (Lausanne) 2021;8:716816. [PMID: 34532332 DOI: 10.3389/fmed.2021.716816] [Reference Citation Analysis]
171 Zhou Y, Zhong B, Min X, Hou Y, Lin L, Wu Q, Shi J, Chen X. Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-κB p65. Phytother Res 2021;35:5861-70. [PMID: 34435401 DOI: 10.1002/ptr.7246] [Reference Citation Analysis]
172 Sun X, Huang Y, Zhang YL, Qiao D, Dai YC. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World J Gastroenterol 2020; 26(48): 7593-7602 [PMID: 33505138 DOI: 10.3748/wjg.v26.i48.7593] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Nardone OM, de Sire R, Petito V, Testa A, Villani G, Scaldaferri F, Castiglione F. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure. Front Immunol 2021;12:694217. [PMID: 34326845 DOI: 10.3389/fimmu.2021.694217] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 López-Posadas R, Stürzl M, Atreya I, Neurath MF, Britzen-Laurent N. Interplay of GTPases and Cytoskeleton in Cellular Barrier Defects during Gut Inflammation. Front Immunol 2017;8:1240. [PMID: 29051760 DOI: 10.3389/fimmu.2017.01240] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
175 Liu N, Sun S, Wang P, Sun Y, Hu Q, Wang X. The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine. Int J Mol Sci 2021;22:7931. [PMID: 34360695 DOI: 10.3390/ijms22157931] [Reference Citation Analysis]
176 Grenier L, Hu P. Computational drug repurposing for inflammatory bowel disease using genetic information. Comput Struct Biotechnol J 2019;17:127-35. [PMID: 30728920 DOI: 10.1016/j.csbj.2019.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
177 Britzen-Laurent N, Herrmann C, Naschberger E, Croner RS, Stürzl M. Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases. World J Gastroenterol 2016; 22(28): 6434-6443 [PMID: 27605879 DOI: 10.3748/wjg.v22.i28.6434] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
178 Radhakrishnan ST, Alexander JL, Mullish BH, Gallagher KI, Powell N, Hicks LC, Hart AL, Li JV, Marchesi JR, Williams HRT. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease. Aliment Pharmacol Ther 2021. [PMID: 34751954 DOI: 10.1111/apt.16656] [Reference Citation Analysis]
179 Zhang F, Li Y, Wang X, Wang S, Bi D. The Impact of Lactobacillus plantarum on the Gut Microbiota of Mice with DSS-Induced Colitis. Biomed Res Int. 2019;2019:3921315. [PMID: 30915354 DOI: 10.1155/2019/3921315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
180 Dong JP, Zheng Y, Wu T, He Q, Teng GG, Wang HH. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice. Chin Med J (Engl) 2019;132:1951-8. [PMID: 31335471 DOI: 10.1097/CM9.0000000000000364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
181 Murakami T, Bodor E, Bodor N. Modulation of expression/function of intestinal P-glycoprotein under disease states. Expert Opinion on Drug Metabolism & Toxicology 2020;16:59-78. [DOI: 10.1080/17425255.2020.1701653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
182 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Reference Citation Analysis]
183 Bsat M, Chapuy L, Rubio M, Wassef R, Richard C, Schwenter F, Loungnarath R, Soucy G, Mehta H, Sarfati M. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients. Front Immunol 2019;10:1177. [PMID: 31191543 DOI: 10.3389/fimmu.2019.01177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
184 Ferreira RDS, Mendonça LABM, Ribeiro CFA, Calças NC, Guimarães RCA, Nascimento VAD, Gielow KCF, Carvalho CME, Castro AP, Franco OL. Relationship between intestinal microbiota, diet and biological systems: an integrated view. Crit Rev Food Sci Nutr 2020;:1-21. [PMID: 33115284 DOI: 10.1080/10408398.2020.1836605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
185 Troiano G, Dioguardi M, Giannatempo G, Laino L, Testa NF, Cocchi R, De Lillo A, Lo Muzio L. Orofacial granulomatosis: clinical signs of different pathologies. Med Princ Pract 2015;24:117-22. [PMID: 25592641 DOI: 10.1159/000369810] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
186 Sun X, Guo C, Zhao F, Zhu J, Xu Y, Liu ZQ, Yang G, Zhang YY, Gu X, Xiao L, Liu Z, Yang PC. Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells. Theranostics 2019;9:2800-11. [PMID: 31244924 DOI: 10.7150/thno.34414] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
187 Mao H, Jia J, Sheng J, Zhang S, Huang K, Li H, He F. Protective and anti-inflammatory role of REG1A in inflammatory bowel disease induced by JAK/STAT3 signaling axis. Int Immunopharmacol 2021;92:107304. [PMID: 33513463 DOI: 10.1016/j.intimp.2020.107304] [Reference Citation Analysis]
188 Lambert K, Pappas D, Miglioretto C, Javadpour A, Reveley H, Frank L, Grimm MC, Samocha-Bonet D, Hold GL. Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:742-54. [PMID: 34323292 DOI: 10.1111/apt.16549] [Reference Citation Analysis]
189 Kikut J, Konecka N, Ziętek M, Kulpa D, Szczuko M. Diet supporting therapy for inflammatory bowel diseases. Eur J Nutr 2021;60:2275-91. [PMID: 33788019 DOI: 10.1007/s00394-021-02489-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Nie J, Zhao Q. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4+ T Cell Activation, Proliferation and Th1/Th17 Cell Differentiation by Serving as a ceRNA for IL-23R via Sponging miR-125a in Inflammatory Bowel Disease. Front Immunol 2020;11:852. [PMID: 32547537 DOI: 10.3389/fimmu.2020.00852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
191 Raja TW, Veeramuthu D, Savarimuthu I, Al-Dhabi NA. Current Trends in the Treatment of Systemic Lupus Erythematosus. Curr Pharm Des 2020;26:2602-9. [PMID: 32066358 DOI: 10.2174/1381612826666200211122633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
192 Li C, Ai G, Wang Y, Lu Q, Luo C, Tan L, Lin G, Liu Y, Li Y, Zeng H, Chen J, Lin Z, Xian Y, Huang X, Xie J, Su Z. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Pharmacological Research 2020;152:104603. [DOI: 10.1016/j.phrs.2019.104603] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 16.0] [Reference Citation Analysis]
193 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
194 Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 2016; 22(42): 9300-9313 [PMID: 27895418 DOI: 10.3748/wjg.v22.i42.9300] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 83] [Article Influence: 15.2] [Reference Citation Analysis]
195 Chong KP, Woo BK. Emerging wearable technology applications in gastroenterology: A review of the literature. World J Gastroenterol 2021; 27(12): 1149-1160 [PMID: 33828391 DOI: 10.3748/wjg.v27.i12.1149] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016;9:229-239. [PMID: 26929784 DOI: 10.1177/1756283x15607414] [Cited by in Crossref: 142] [Cited by in F6Publishing: 70] [Article Influence: 23.7] [Reference Citation Analysis]
197 Tonecka K, Braniewska A, Pilch Z, Sas Z, Skorzynski M, Manuali E, Rygiel TP. The CD200 Regulates Inflammation in Mice Independently of TNF-α Production. Int J Mol Sci 2021;22:5358. [PMID: 34069671 DOI: 10.3390/ijms22105358] [Reference Citation Analysis]
198 Yu H, Yang X, Xiao X, Xu M, Yang Y, Xue C, Li X, Wang S, Zhao RC. Human Adipose Mesenchymal Stem Cell-derived Exosomes Protect Mice from DSS-Induced Inflammatory Bowel Disease by Promoting Intestinal-stem-cell and Epithelial Regeneration. Aging Dis 2021;12:1423-37. [PMID: 34527419 DOI: 10.14336/AD.2021.0601] [Reference Citation Analysis]
199 Fu W, Fu H, Ye W, Han Y, Liu X, Zhu S, Li H, Tang R, Wang Q. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. Int Immunopharmacol 2021;101:108235. [PMID: 34678692 DOI: 10.1016/j.intimp.2021.108235] [Reference Citation Analysis]
200 Reeves MA, Royal JM, Morris DA, Jurkiewicz JM, Matoba N, Hamorsky KT. Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing. Pharmaceutics 2021;13:576. [PMID: 33919585 DOI: 10.3390/pharmaceutics13040576] [Reference Citation Analysis]
201 Capitano ML, Jaiswal A, Broxmeyer HE, Pride Y, Glover S, Amlashi FG, Kirby A, Srinivasan G, Williamson EA, Mais D, Hromas R. A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease. PLoS One 2021;16:e0252805. [PMID: 34197491 DOI: 10.1371/journal.pone.0252805] [Reference Citation Analysis]
202 Wu Q, Cao F, Tao J, Li X, Zheng SG, Pan HF. Pentraxin 3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev 2020;19:102584. [PMID: 32534154 DOI: 10.1016/j.autrev.2020.102584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
203 Rojas A, Schneider I, Lindner C, Gonzàlez I, Morales MA. Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison? World J Gastroenterol 2021; 27(19): 2270-2280 [PMID: 34040321 DOI: 10.3748/wjg.v27.i19.2270] [Reference Citation Analysis]
204 Wang Z, Zhu J, Liu C, Ma L. Identification of key genes and pathways associated with Crohn's disease by bioinformatics analysis. Scand J Gastroenterol 2019;54:1205-13. [PMID: 31526198 DOI: 10.1080/00365521.2019.1665096] [Reference Citation Analysis]
205 Peters V, Tigchelaar-Feenstra EF, Imhann F, Dekens JAM, Swertz MA, Franke LH, Wijmenga C, Weersma RK, Alizadeh BZ, Dijkstra G, Campmans-Kuijpers MJE. Habitual dietary intake of IBD patients differs from population controls: a case-control study. Eur J Nutr 2021;60:345-56. [PMID: 32333097 DOI: 10.1007/s00394-020-02250-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
206 Yu L, Zhao D, Nian Y, Li C. Casein-fed mice showed faster recovery from DSS-induced colitis than chicken-protein-fed mice. Food Funct 2021;12:5806-20. [PMID: 34047734 DOI: 10.1039/d1fo00659b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Bäcker V, Cheung FY, Siveke JT, Fandrey J, Winning S. Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis. PLoS One 2017;12:e0190074. [PMID: 29261815 DOI: 10.1371/journal.pone.0190074] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
208 Abdo AIK, Tye GJ. Interleukin 23 and autoimmune diseases: current and possible future therapies. Inflamm Res 2020;69:463-80. [PMID: 32215665 DOI: 10.1007/s00011-020-01339-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
209 Quagliariello A, Del Chierico F, Reddel S, Russo A, Onetti Muda A, D'Argenio P, Angelino G, Romeo EF, Dall'Oglio L, De Angelis P, Putignani L, All The Other Fmt Opbg Committee Collaborators. Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations. Microorganisms 2020;8:E1486. [PMID: 32992653 DOI: 10.3390/microorganisms8101486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
210 Zaidi D, Bording-Jorgensen M, Huynh HQ, Carroll MW, Turcotte JF, Sergi C, Liu J, Wine E. Increased Epithelial Gap Density in the Noninflamed Duodenum of Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;63:644-50. [PMID: 26933801 DOI: 10.1097/MPG.0000000000001182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
211 Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, Liu Q, Li K, Wang W, Wang H, Xie W, Wang Q, Liu J, Zheng B, Zhang P, Huang S, Shi T, Zhang B, Dang Y, Chen J, O'Malley BW, Moses RE, Wang P, Li L, Xiao J, Hoffmann A, Li X. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun 2016;7:10761. [PMID: 26899380 DOI: 10.1038/ncomms10761] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
212 Zhou H, Zeng X, Sun D, Chen Z, Chen W, Fan L, Limpanont Y, Dekumyoy P, Maleewong W, Lv Z. Monosexual Cercariae of Schistosoma japonicum Infection Protects Against DSS-Induced Colitis by Shifting the Th1/Th2 Balance and Modulating the Gut Microbiota. Front Microbiol 2020;11:606605. [PMID: 33469451 DOI: 10.3389/fmicb.2020.606605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Eissa N, Hussein H, Tshikudi DM, Hendy GN, Bernstein CN, Ghia JE. Interdependence between Chromogranin-A, Alternatively Activated Macrophages, Tight Junction Proteins and the Epithelial Functions. A Human and In-Vivo/In-Vitro Descriptive Study. Int J Mol Sci 2020;21:E7976. [PMID: 33121008 DOI: 10.3390/ijms21217976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Akutko K, Stawarski A. Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases. J Clin Med 2021;10:2466. [PMID: 34199428 DOI: 10.3390/jcm10112466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Dragasevic S, Stankovic B, Milosavljevic T, Sokic-Milutinovic A, Lukic S, Alempijevic T, Zukic B, Kotur N, Nikcevic G, Pavlovic S, Popovic D. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2017;29:909-15. [PMID: 28452812 DOI: 10.1097/MEG.0000000000000877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
216 Barbalho SM, Bosso H, Salzedas-Pescinini LM, de Alvares Goulart R. Green tea: A possibility in the therapeutic approach of inflammatory bowel diseases?: Green tea and inflammatory bowel diseases. Complement Ther Med 2019;43:148-53. [PMID: 30935522 DOI: 10.1016/j.ctim.2019.01.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
217 Izzo R, Bevivino G, Monteleone G. Tofacitinib for the treatment of ulcerative colitis. Expert Opin Investig Drugs 2016;25:991-7. [PMID: 27177233 DOI: 10.1080/13543784.2016.1189900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
218 Gubatan J, Mitsuhashi S, Zenlea T, Rosenberg L, Robson S, Moss AC. Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol 2017; 15: 240-246. e1. [PMID: 27266980 DOI: 10.1016/j.cgh.2016.05.035] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
219 Valvano M, Magistroni M, Mancusi A, D'Ascenzo D, Longo S, Stefanelli G, Vernia F, Viscido A, Necozione S, Latella G. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics. Nutrients 2021;13:323. [PMID: 33499406 DOI: 10.3390/nu13020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Senthamizhselvan K, Ramalingam R, Mohan P, Kavadichanda C, Badhe B, Hamide A. De Novo Crohn's Disease Triggered After COVID-19: Is COVID-19 More Than an Infectious Disease? ACG Case Rep J 2021;8:e00652. [PMID: 34476279 DOI: 10.14309/crj.0000000000000652] [Reference Citation Analysis]
221 Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ. Modulating the immune system through nanotechnology. Semin Immunol 2017;34:78-102. [PMID: 29032891 DOI: 10.1016/j.smim.2017.09.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 10.4] [Reference Citation Analysis]
222 Li M, Liu X, Liu Z, Hong J, Liu J, Zhou C, Hu T, Xiao X, Ran P, Zheng P, Liu Z, Yang P. Bcl2L12 Contributes to Th2-Biased Inflammation in the Intestinal Mucosa by Regulating CD4 + T Cell Activities. J I 2018;201:725-33. [DOI: 10.4049/jimmunol.1800139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
223 Zhang H, Wang L, Li C, Yu Y, Yi Y, Wang J, Chen D. Exosome-Induced Regulation in Inflammatory Bowel Disease. Front Immunol. 2019;10:1464. [PMID: 31316512 DOI: 10.3389/fimmu.2019.01464] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
224 Yang Y, Zhu X, Qin Y, Chen G, Zhou J, Li L, Guan J, Ma L, Xue Y, Li C. The Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model. Evid Based Complement Alternat Med 2017;2017:8547257. [PMID: 28845184 DOI: 10.1155/2017/8547257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
225 Sánchez-Fidalgo S, Villegas I, Aparicio-Soto M, Cárdeno A, Rosillo MÁ, González-Benjumea A, Marset A, López Ó, Maya I, Fernández-Bolaños JG, Alarcón de la Lastra C. Effects of dietary virgin olive oil polyphenols: hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. J Nutr Biochem 2015;26:513-20. [PMID: 25736481 DOI: 10.1016/j.jnutbio.2014.12.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
226 Seregin SS, Golovchenko N, Schaf B, Chen J, Pudlo NA, Mitchell J, Baxter NT, Zhao L, Schloss PD, Martens EC, Eaton KA, Chen GY. NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila. Cell Rep 2017;19:733-45. [PMID: 28445725 DOI: 10.1016/j.celrep.2017.03.080] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 29.0] [Reference Citation Analysis]
227 Van Buiten CB, Lambert JD, Elias RJ. Green Tea Polyphenols Mitigate Gliadin-Mediated Inflammation and Permeability in Vitro. Mol Nutr Food Res 2018;62:e1700879. [PMID: 29704403 DOI: 10.1002/mnfr.201700879] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
228 Rallabandi HR, Yang H, Oh KB, Lee HC, Byun SJ, Lee BR. Evaluation of Intestinal Epithelial Barrier Function in Inflammatory Bowel Diseases Using Murine Intestinal Organoids. Tissue Eng Regen Med 2020;17:641-50. [PMID: 32594459 DOI: 10.1007/s13770-020-00278-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
229 Fábrega MJ, Rodríguez-Nogales A, Garrido-Mesa J, Algieri F, Badía J, Giménez R, Gálvez J, Baldomà L. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Front Microbiol 2017;8:1274. [PMID: 28744268 DOI: 10.3389/fmicb.2017.01274] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
230 Brunner A, Kruis W, Schömig-Markiefka B, Morgenstern J, Engels M, Büttner R, Forner DM. Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study. J Cancer Res Clin Oncol 2022. [PMID: 34981194 DOI: 10.1007/s00432-021-03909-8] [Reference Citation Analysis]
231 Arthur S, Palaniappan B, Afroz S, Sundaram U. Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation. Inflamm Bowel Dis 2021:izab093. [PMID: 34019094 DOI: 10.1093/ibd/izab093] [Reference Citation Analysis]
232 Kristjánsson VB, Lund SH, Gröndal G, Sveinsdóttir SV, Agnarsson HR, Jónasson JG, Björnsson ES. Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Scand J Gastroenterol 2021;56:46-52. [PMID: 33280485 DOI: 10.1080/00365521.2020.1854847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
233 Al-Jarallah A, Oriowo M. The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis. PLoS One 2017;12:e0170792. [PMID: 28493876 DOI: 10.1371/journal.pone.0170792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
234 Chen YE, Xu SJ, Lu YY, Chen SX, Du XH, Hou SZ, Huang HY, Liang J. Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathways. Chem Biol Interact 2021;344:109512. [PMID: 33974900 DOI: 10.1016/j.cbi.2021.109512] [Reference Citation Analysis]
235 Li K, Hao Z, Du J, Gao Y, Yang S, Zhou Y. Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4+T cell homeostasis. Int Immunopharmacol 2021;90:107183. [PMID: 33229197 DOI: 10.1016/j.intimp.2020.107183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
237 Zhu S, Huang M, Feng G, Miao Y, Wu H, Zeng M, Lo YM. Gelatin versus its two major degradation products, prolyl-hydroxyproline and glycine, as supportive therapy in experimental colitis in mice. Food Sci Nutr 2018;6:1023-31. [PMID: 29983966 DOI: 10.1002/fsn3.639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
238 Pabari RM, Mattu C, Partheeban S, Almarhoon A, Boffito M, Ciardelli G, Ramtoola Z. Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model. Int J Pharm 2019;565:533-42. [PMID: 31085256 DOI: 10.1016/j.ijpharm.2019.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
239 Kubackova J, Holas O, Zbytovska J, Vranikova B, Zeng G, Pavek P, Mullertz A. Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS). Pharmaceutics 2021;13:459. [PMID: 33800701 DOI: 10.3390/pharmaceutics13040459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
240 Tsao NW, Sayre EC, Hanley G, Sadatsafavi M, Lynd LD, Marra CA, De Vera MA. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. Ann Rheum Dis 2018;77:869-74. [PMID: 29496718 DOI: 10.1136/annrheumdis-2018-213023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
241 Choi SJ, Kim MS, Kim ES, Lee J, Lee JM, Choi HS, Keum B, Jeen YT, Lee HS, Chun HJ, Kim CD. Higher risk of tuberculosis in combination therapy for inflammatory bowel disease: A nationwide population-based cohort study in South Korea. Medicine (Baltimore) 2020;99:e22897. [PMID: 33126343 DOI: 10.1097/MD.0000000000022897] [Reference Citation Analysis]
242 Kim KU, Kim J, Kim WH, Min H, Choi CH. Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharm Res 2021;44:293-309. [PMID: 33763844 DOI: 10.1007/s12272-021-01318-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
243 Bhattacharjee A, Szabó Á, Csizmadia T, Laczkó-Dobos H, Juhász G. Understanding the importance of autophagy in human diseases using Drosophila. J Genet Genomics 2019;46:157-69. [PMID: 31080044 DOI: 10.1016/j.jgg.2019.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
244 Arun KB, Madhavan A, Sindhu R, Emmanual S, Binod P, Pugazhendhi A, Sirohi R, Reshmy R, Awasthi MK, Gnansounou E, Pandey A. Probiotics and gut microbiome - Prospects and challenges in remediating heavy metal toxicity. J Hazard Mater 2021;420:126676. [PMID: 34329091 DOI: 10.1016/j.jhazmat.2021.126676] [Reference Citation Analysis]
245 Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. J Clin Med 2020;9:E1273. [PMID: 32354192 DOI: 10.3390/jcm9051273] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
246 Lin R, Wang Z, Cao J, Gao T, Dong Y, Chen Y. Role of melatonin in murine "restraint stress"-induced dysfunction of colonic microbiota. J Microbiol 2021;59:500-12. [PMID: 33630247 DOI: 10.1007/s12275-021-0305-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Couceiro J, Matos I, Mendes JJ, Baptista PV, Fernandes AR, Quintas A. Inflammatory factors, genetic variants, and predisposition for preterm birth. Clin Genet 2021;100:357-67. [PMID: 34013526 DOI: 10.1111/cge.14001] [Reference Citation Analysis]
248 Yuan YY, Liu YJ, Fan H. New progress in research of Th17 cells and related cytokines in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1402-1409 [DOI: 10.11569/wcjd.v29.i24.1402] [Reference Citation Analysis]
249 Raj V, Venkataraman B, Almarzooqi S, Chandran S, Ojha SK, Attoub S, Adrian TE, Subramanya SB. Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models. Nutrients 2020;12:E2032. [PMID: 32650602 DOI: 10.3390/nu12072032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
250 Wu M, Shen A, Chen Y, Liu L, Li L, Sankararaman S, Chen H, Guan B, Zhan Z, Nan S, Sferra TJ, Peng J. Xinhuang Tablets Improve Intestinal Barrier Function via Regulating Epithelial Tight Junctions in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice. J Med Food 2021;24:33-9. [PMID: 32522051 DOI: 10.1089/jmf.2020.0008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Li H, Christman LM, Li R, Gu L. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases. Food Funct 2020;11:4878-91. [PMID: 32490857 DOI: 10.1039/d0fo00713g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
252 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
253 Fairhurst NG, Travis SPL. Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis? Intest Res 2018;16:209-15. [PMID: 29743833 DOI: 10.5217/ir.2018.16.2.209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
254 Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61:111-28. [PMID: 30196243 DOI: 10.1016/j.jnutbio.2018.07.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
255 Seo K, Seo J, Yeun J, Choi H, Kim YI, Chang SY. The role of mucosal barriers in human gut health. Arch Pharm Res 2021;44:325-41. [PMID: 33890250 DOI: 10.1007/s12272-021-01327-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
256 Zhang HN, Zhou XD, Xu X, Wang Y. [Oral microbiota and inflammatory bowel disease]. Hua Xi Kou Qiang Yi Xue Za Zhi 2019;37:443-9. [PMID: 31512842 DOI: 10.7518/hxkq.2019.04.020] [Reference Citation Analysis]
257 Moeser A, Lerche M, Wirtz H, Stallmach A. [Aspects of pulmonary involvement in inflammatory bowel disease]. Internist (Berl) 2018;59:876-85. [PMID: 30116854 DOI: 10.1007/s00108-018-0473-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
258 Szczepaniak A, Fichna J. Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer-a Critical Review. Biomolecules 2019;9:E398. [PMID: 31443436 DOI: 10.3390/biom9090398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
259 Katsaros M, Paschos P, Giouleme O. Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review. Ann Gastroenterol 2020;33:348-54. [PMID: 32624654 DOI: 10.20524/aog.2020.0486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Weber L, Kuck K, Jürgenliemk G, Heilmann J, Lipowicz B, Vissiennon C. Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa. Biomolecules 2020;10:E1033. [PMID: 32664498 DOI: 10.3390/biom10071033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
261 Shawki A, McCole DF. Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli. Cell Mol Gastroenterol Hepatol 2017;3:41-50. [PMID: 28174756 DOI: 10.1016/j.jcmgh.2016.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
262 Swanson HI. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry? Drug Metab Dispos. 2015;43:1499-1504. [PMID: 26261284 DOI: 10.1124/dmd.115.065714] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 11.9] [Reference Citation Analysis]
263 Manz A, Allenspach K, Kummer S, Richter B, Walter I, Macho-Maschler S, Tichy A, Burgener IA, Luckschander-Zeller N. Upregulation of signal transducer and activator of transcription 3 in dogs with chronic inflammatory enteropathies. J Vet Intern Med 2021;35:1288-96. [PMID: 33955083 DOI: 10.1111/jvim.16141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
264 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
265 Tsao NW, Rebic N, Lynd LD, De Vera MA. Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2020;59:1808-17. [PMID: 32118278 DOI: 10.1093/rheumatology/keaa064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
266 Tyrrell H, Ravanello R, Pulley J, Tang MT, Zhang W, Abouhossein M, Tole S. An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers. Adv Ther 2021;38:2406-17. [PMID: 33778928 DOI: 10.1007/s12325-021-01651-8] [Reference Citation Analysis]
267 Ma Z, Zhen Y, Hu C, Yi H. Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice. Front Immunol 2020;11:687. [PMID: 32391010 DOI: 10.3389/fimmu.2020.00687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
268 Gomes TNF, de Azevedo FS, Argollo M, Miszputen SJ, Ambrogini O Jr. Clinical and Demographic Profile of Inflammatory Bowel Disease Patients in a Reference Center of São Paulo, Brazil. Clin Exp Gastroenterol 2021;14:91-102. [PMID: 33762838 DOI: 10.2147/CEG.S288688] [Reference Citation Analysis]
269 Tadin Hadjina I, Zivkovic PM, Matetic A, Rusic D, Vilovic M, Bajo D, Puljiz Z, Tonkic A, Bozic J. Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep. 2019;9:13740. [PMID: 31551482 DOI: 10.1030/s41598-019-50192-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
270 Chapuy L, Bsat M, Rubio M, Harvey F, Motta V, Schwenter F, Wassef R, Richard C, Deslandres C, Nguyen BN, Soucy G, Hacohen N, Fritz J, Villani AC, Mehta H, Sarfati M. Transcriptomic Analysis and High-dimensional Phenotypic Mapping of Mononuclear Phagocytes in Mesenteric Lymph Nodes Reveal Differences Between Ulcerative Colitis and Crohn's Disease. J Crohns Colitis 2020;14:393-405. [PMID: 31541232 DOI: 10.1093/ecco-jcc/jjz156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
271 Gorabi AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, Jamialahmadi T, Johnston TP, Sahebkar A. The pivotal role of CD69 in autoimmunity. J Autoimmun 2020;111:102453. [PMID: 32291138 DOI: 10.1016/j.jaut.2020.102453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Pang B, Jin H, Liao N, Li J, Jiang C, Shi J. Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota-dependent manner. Food Res Int 2021;148:110568. [PMID: 34507723 DOI: 10.1016/j.foodres.2021.110568] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
273 Chang YL, Lo HY, Cheng SP, Chang KT, Lin XF, Lee SP, Hsieh MF, Chan CK. Therapeutic effects of a single injection of human umbilical mesenchymal stem cells on acute and chronic colitis in mice. Sci Rep 2019;9:5832. [PMID: 30967579 DOI: 10.1038/s41598-019-41910-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
274 Aranda CJ, Arredondo-Amador M, Ocón B, Lavín JL, Aransay AM, Martínez-Augustin O, Sánchez de Medina F. Intestinal epithelial deletion of the glucocorticoid receptor NR3C1 alters expression of inflammatory mediators and barrier function. FASEB J 2019;33:14067-82. [PMID: 31657630 DOI: 10.1096/fj.201900404RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
275 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
276 Dudzińska E, Szymona K, Kloc R, Gil-Kulik P, Kocki T, Świstowska M, Bogucki J, Kocki J, Urbanska EM. Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819881304. [PMID: 31666808 DOI: 10.1177/1756284819881304] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
277 Mańkowska-Wierzbicka D, Stelmach-Mardas M, Gabryel M, Tomczak H, Skrzypczak-Zielińska M, Zakerska-Banaszak O, Sowińska A, Mahadea D, Baturo A, Wolko Ł, Słomski R, Dobrowolska A. The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study. Biomedicines 2020;8:E268. [PMID: 32756350 DOI: 10.3390/biomedicines8080268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
278 Ke H, Li F, Deng W, Li Z, Wang S, Lv P, Chen Y. Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis. Front Pharmacol 2021;12:726707. [PMID: 34658866 DOI: 10.3389/fphar.2021.726707] [Reference Citation Analysis]
279 Salmenkari H, Korpela R, Vapaatalo H. Renin-angiotensin system in intestinal inflammation-Angiotensin inhibitors to treat inflammatory bowel diseases? Basic Clin Pharmacol Toxicol 2021;129:161-72. [PMID: 34128327 DOI: 10.1111/bcpt.13624] [Reference Citation Analysis]
280 Johansson ME. Mucus layers in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:2124-31. [PMID: 25025717 DOI: 10.1097/MIB.0000000000000117] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 8.9] [Reference Citation Analysis]
281 van den Heuvel TR, Jonkers DM, Jeuring SF, Romberg-camps MJ, Oostenbrug LE, Zeegers MP, Masclee AA, Pierik MJ. Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL). International Journal of Epidemiology 2017;46:e7-e7. [DOI: 10.1093/ije/dyv088] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
282 Alfwuaires MA, Algefare AI, Afkar E, Salam SA, El-Moaty HIA, Badr GM. Immunomodulatory assessment of Portulaca oleracea L. extract in a mouse model of colitis. Biomed Pharmacother 2021;143:112148. [PMID: 34560553 DOI: 10.1016/j.biopha.2021.112148] [Reference Citation Analysis]
283 Castro-Ochoa KF, Vargas-Robles H, Chánez-Paredes S, Felipe-López A, Cabrera-Silva RI, Shibayama M, Betanzos A, Nava P, Galinski EA, Schnoor M. Homoectoine Protects Against Colitis by Preventing a Claudin Switch in Epithelial Tight Junctions. Dig Dis Sci 2019;64:409-20. [PMID: 30269272 DOI: 10.1007/s10620-018-5309-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
284 Sharifi A, Vahedi H, Honarvar MR, Amiriani T, Nikniaz Z, Rad EY, Hosseinzadeh-Attar MJ. Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebo-controlled trial. Turk J Gastroenterol 2020;31:99-104. [PMID: 32141817 DOI: 10.5152/tjg.2020.181028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
285 Wang W, Zhai D, Bai Y, Xue K, Deng L, Ma L, Du T, Ye Z, Qu D, Xiang A, Chen G, Zhao Y, Wang L, Lu Z. Loss of QKI in macrophage aggravates inflammatory bowel disease through amplified ROS signaling and microbiota disproportion. Cell Death Discov 2021;7:58. [PMID: 33758177 DOI: 10.1038/s41420-021-00444-w] [Reference Citation Analysis]
286 Guo S, Geng W, Chen S, Wang L, Rong X, Wang S, Wang T, Xiong L, Huang J, Pang X, Lu Y. Ginger Alleviates DSS-Induced Ulcerative Colitis Severity by Improving the Diversity and Function of Gut Microbiota. Front Pharmacol 2021;12:632569. [PMID: 33692694 DOI: 10.3389/fphar.2021.632569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
287 Kondubhatla K, Kaushal A, Daoud A, Shabbir H, Mostafa JA. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020;12:e10544. [PMID: 33062549 DOI: 10.7759/cureus.10544] [Reference Citation Analysis]
288 Chen M, Tian S, Li S, Pang X, Sun J, Zhu X, Lv F, Lu Z, Li X. β-Glucan Extracted from Highland Barley Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57BL/6J Mice. Molecules 2021;26:5812. [PMID: 34641356 DOI: 10.3390/molecules26195812] [Reference Citation Analysis]
289 Szollosi DE, Manzoor MK, Aquilato A, Jackson P, Ghoneim OM, Edafiogho IO. Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseases. Journal of Pharmacy and Pharmacology 2018;70:18-26. [DOI: 10.1111/jphp.12811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
290 Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med 2019;14:23. [PMID: 31236131 DOI: 10.1186/s13020-019-0245-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
291 Feng YJ, Li YY, Lin XH, Li K, Cao MH. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. World J Gastroenterol 2016; 22(43): 9515-9524 [PMID: 27920472 DOI: 10.3748/wjg.v22.i43.9515] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
292 Ferreira RDS, Mendonça LABM, Santos CD, Hiane PA, Matias R, Franco OL, de Oliveira AKM, do Nascimento VA, Pott A, Carvalho CME, Guimarães RCA. Do Bioactive Food Compound with Avena sativa L., Linum usitatissimum L. and Glycine max L. Supplementation with Moringa oleifera Lam. Have a Role against Nutritional Disorders? An Overview of the In Vitro and In Vivo Evidence. Nutrients 2021;13:2294. [PMID: 34371804 DOI: 10.3390/nu13072294] [Reference Citation Analysis]
293 Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? Ann Rheum Dis 2018;77:175-87. [PMID: 28765121 DOI: 10.1136/annrheumdis-2017-211555] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 31.8] [Reference Citation Analysis]
294 Włodarczyk M, Sobolewska-włodarczyk A, Stec-michalska K, Fichna J, Wiśniewska-jarosińska M. The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases. Pharmacological Reports 2016;68:852-8. [DOI: 10.1016/j.pharep.2016.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
295 Kao L, Lin H, Lee H. Inflammatory bowel disease and bipolar disorder: A population-based cross-sectional study. Journal of Affective Disorders 2019;247:120-4. [DOI: 10.1016/j.jad.2019.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
296 Hanić M, Trbojević-Akmačić I, Lauc G. Inflammatory bowel disease - glycomics perspective. Biochim Biophys Acta Gen Subj 2019;1863:1595-601. [PMID: 31276732 DOI: 10.1016/j.bbagen.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
297 Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220-246. [PMID: 31352652 DOI: 10.1007/s12664-019-00976-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
298 Abdalla LF, Chaudhry Ehsanullah R, Karim F, Oyewande AA, Khan S. Role of Using Nonsteroidal Anti-Inflammatory Drugs in Chemoprevention of Colon Cancer in Patients With Inflammatory Bowel Disease. Cureus 2020;12:e8240. [PMID: 32582499 DOI: 10.7759/cureus.8240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
299 Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M, Martinovic D, Bratanic A, Lizatovic IK, Bozic J. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics 2022;12:45. [DOI: 10.3390/diagnostics12010045] [Reference Citation Analysis]
300 El Jammal T, Gerfaud-Valentin M, Sève P, Jamilloux Y. [JAK inhibitors: Perspectives in internal medicine]. Rev Med Interne 2019;40:816-25. [PMID: 31699450 DOI: 10.1016/j.revmed.2019.07.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
301 Xu P, Elamin E, Elizalde M, Bours PPHA, Pierik MJ, Masclee AAM, Jonkers DMAE. Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model. Sci Rep 2019;9:2030. [PMID: 30765731 DOI: 10.1038/s41598-018-38322-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
302 Wilson DC, Russell RK. Overview of paediatric IBD. Seminars in Pediatric Surgery 2017;26:344-8. [DOI: 10.1053/j.sempedsurg.2017.10.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
303 Park S, Kim J, Chun J, Han K, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study. J Clin Med. 2019;8. [PMID: 31398905 DOI: 10.3390/jcm8081191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
304 Park S, Chun J, Han KD, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Dose-response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol. 2019;54:881-890. [PMID: 31093771 DOI: 10.1007/s00535-019-01589-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
305 Boutemine IM, Amri M, Dorgham K, Amir ZC, Benazzouz S, Ameur F, Layaida K, Yssel H, Touil-Boukoffa C. Beneficial role of Pistacia lentiscus aqueous extract in experimental colitis: anti-inflammatory and potential therapeutic effects. Inflammopharmacology 2021;29:1225-39. [PMID: 34115225 DOI: 10.1007/s10787-021-00831-w] [Reference Citation Analysis]
306 Ye Q, Hu Z, Yang M, Qin K, Zhou Y. Effects and mechanisms of Chinese herbal medicine for ulcerative colitis: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19768. [PMID: 32311981 DOI: 10.1097/MD.0000000000019768] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
307 Loddo I, Romano C. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol. 2015;6:551. [PMID: 26579126 DOI: 10.3389/fimmu.2015.00551] [Cited by in Crossref: 166] [Cited by in F6Publishing: 142] [Article Influence: 23.7] [Reference Citation Analysis]
308 Wei Z, Yuan J, Wang G, Ocansey DKW, Xu Z, Mao F. Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases. Stem Cells Int 2021;2021:5583994. [PMID: 33859701 DOI: 10.1155/2021/5583994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019;558:201-14. [DOI: 10.1016/j.ijpharm.2018.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
310 Gordon MH, Chauvin A, Boisvert FM, MacNaughton WK. Proteolytic Processing of the Epithelial Adherens Junction Molecule E-Cadherin by Neutrophil Elastase Generates Short Peptides With Novel Wound-Healing Bioactivity. Cell Mol Gastroenterol Hepatol 2019;7:483-486.e8. [PMID: 30827416 DOI: 10.1016/j.jcmgh.2018.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
311 Sobolewska-Włodarczyk A, Włodarczyk M, Szemraj J, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M. Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease. Pharmacol Rep 2016;68:847-51. [PMID: 27166084 DOI: 10.1016/j.pharep.2016.04.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
312 Pękala A, Filip R. Levels of Biosimilar Infliximab during and after Induction Treatment in Crohn's Disease and Ulcerative Colitis-A Prospective Polish Population Study. J Clin Med 2021;10:5311. [PMID: 34830598 DOI: 10.3390/jcm10225311] [Reference Citation Analysis]
313 Feng BS, Ma N, Zhang YY, Gao H, Zhang C, Li G, Liu Z, Feng Y, Yu HQ, Xiao L, Liu ZG, Yang PC. Survivin Impairs the Apoptotic Machinery in CD4+ T Cells of Patients with Ulcerative Colitis. J Innate Immun 2020;12:226-34. [PMID: 31330513 DOI: 10.1159/000500546] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
314 He F, Wu C, Li P, Li N, Zhang D, Zhu Q, Ren W, Peng Y. Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation. Biomed Res Int. 2018;2018:1-13. [PMID: 29682569 DOI: 10.1155/2018/9171905] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 13.0] [Reference Citation Analysis]
315 Van Buiten CB, Elias RJ. Gliadin Sequestration as a Novel Therapy for Celiac Disease: A Prospective Application for Polyphenols. Int J Mol Sci 2021;22:E595. [PMID: 33435615 DOI: 10.3390/ijms22020595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, Wu Q, You L, Wang Y, Lin Y, Li X, Wang Y, Bian JS, Sun D, Kong L, Birnbaumer L, Yang Y. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci USA. 2018;115:E2960-E2969. [PMID: 29531080 DOI: 10.1073/pnas.1720696115] [Cited by in Crossref: 108] [Cited by in F6Publishing: 105] [Article Influence: 27.0] [Reference Citation Analysis]
317 Pagan-Leon S, Werbel T, Montanez-Wiscovich M. Tumor Necrosis Factor Inhibitor-Induced Eczematous Eruption: A Report of Two Cases and Review of the Literature. Cureus 2021;13:e15078. [PMID: 34159000 DOI: 10.7759/cureus.15078] [Reference Citation Analysis]
318 Zaylaa M, Al Kassaa I, Alard J, Peucelle V, Boutillier D, Desramaut J, Dabboussi F, Pot B, Grangette C. Probiotics in IBD: Combining in vitro and in vivo models for selecting strains with both anti-inflammatory potential as well as a capacity to restore the gut epithelial barrier. Journal of Functional Foods 2018;47:304-15. [DOI: 10.1016/j.jff.2018.05.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
319 Dong W, Liu D, Zhang T, You Q, Huang F, Wu J. Oral delivery of staphylococcal nuclease ameliorates DSS induced ulcerative colitis in mice via degrading intestinal neutrophil extracellular traps. Ecotoxicol Environ Saf 2021;215:112161. [PMID: 33812202 DOI: 10.1016/j.ecoenv.2021.112161] [Reference Citation Analysis]
320 Cao Q, Gao X, Lin Y, Yue C, Wang Y, Quan F, Zhang Z, Liu X, Lu Y, Zhan Y, Yang H, Li X, Qin D, Birnbaumer L, Hao K, Yang Y. Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes. Theranostics 2019;9:7490-505. [PMID: 31695782 DOI: 10.7150/thno.35015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
321 Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M, Kumric M, Tokic D, Supe-Domic D, Lupi-Ferandin S, Bozic J. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(36): 6142-6153 [PMID: 34629825 DOI: 10.3748/wjg.v27.i36.6142] [Reference Citation Analysis]
322 Bennebroek Evertsz' F, Sprangers MAG, de Vries LM, Sanderman R, Stokkers PCF, Verdam MGE, Burger H, Bockting CLH. I am a total failure: associations between beliefs and anxiety and depression in patients with inflammatory bowel disease with poor mental quality of life. Behav Cogn Psychother 2020;48:91-102. [PMID: 31423955 DOI: 10.1017/S1352465819000444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Majidova K, Handfield J, Kafi K, Martin RD, Kubinski R. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes (Basel) 2021;12:1465. [PMID: 34680860 DOI: 10.3390/genes12101465] [Reference Citation Analysis]
324 Duan R, Wu Y, Wang M, Wu J, Wang X, Wang Z, Hu Y, Duan L. Association between short-term exposure to fine particulate pollution and outpatient visits for ulcerative colitis in Beijing, China: A time-series study. Ecotoxicol Environ Saf 2021;214:112116. [PMID: 33706140 DOI: 10.1016/j.ecoenv.2021.112116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 2020; 26(30): 4378-4393 [PMID: 32874052 DOI: 10.3748/wjg.v26.i30.4378] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
326 AlSaleem K, El Mouzan MI, Saadah OI, AlSaleem B, Al-Hussaini A, Hassosa M, Ali AM, Banemai MO, Halaby H, El Edreesi M. Characteristics of pediatric ulcerative colitis in Saudi Arabia: a multicenter national study. Ann Saudi Med. 2015;35:19-22. [PMID: 26142933 DOI: 10.5144/0256-4947.2015.19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
327 Monteros MJM, Galdeano CM, Balcells MF, Weill R, De Paula JA, Perdigón G, Cazorla SI. Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug. Sci Rep 2021;11:571. [PMID: 33436961 DOI: 10.1038/s41598-020-80482-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
328 Abdelahad M, Ta E, Kesselman MM, Demory Beckler M. A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients. Cureus 2021;13:e15016. [PMID: 34136315 DOI: 10.7759/cureus.15016] [Reference Citation Analysis]
329 Shahmohammadi S, Sahraian MA, Shahmohammadi A, Doosti R, Zare-Mirzaie A, Naser Moghadasi A. A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review. Mult Scler Relat Disord 2018;22:22-6. [PMID: 29524758 DOI: 10.1016/j.msard.2018.02.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
330 Papalia I, Tjandra D, Quah S, Tan C, Gorelik A, Sivanesan S, Macrae F. Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease. Inflamm Bowel Dis 2021;27:S25-32. [PMID: 34791289 DOI: 10.1093/ibd/izab180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Jo H, Eom YW, Kim HS, Park HJ, Kim HM, Cho MY. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice. Gut Liver 2018;12:664-73. [PMID: 29938461 DOI: 10.5009/gnl18072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
332 Ramos López L, Hernández Camba A, Rodríguez-Lago I, Carrillo Palau M, Cejas Dorta L, Elorza A, Alonso Abreu I, Vela M, Hidalgo A, Hernández Álvarez-Builla N, Rodríguez GE, Rodríguez Y, Tardillo C, Díaz-Flórez L, Eiroa D, Aduna M, Garrido MS, Larena JA, Cabriada JL, Quintero Carrion E. Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease. Gastroenterol Hepatol 2020;43:439-45. [PMID: 32349904 DOI: 10.1016/j.gastrohep.2020.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
333 Yu Y, Song EM, Lee KE, Joo YH, Kim SE, Moon CM, Kim HY, Jung SA, Jo I. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis. PLoS One 2017;12:e0183141. [PMID: 28854223 DOI: 10.1371/journal.pone.0183141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
334 Bhattarai A, Kowalczyk W, Tran TN. A literature review on large intestinal hyperelastic constitutive modeling. Clin Biomech (Bristol, Avon) 2021;88:105445. [PMID: 34416632 DOI: 10.1016/j.clinbiomech.2021.105445] [Reference Citation Analysis]
335 Kuriyama T, Yamato M, Homma J, Tobe Y, Tokushige K. A novel rat model of inflammatory bowel disease developed using a device created with a 3D printer. Regen Ther 2020;14:1-10. [PMID: 31970267 DOI: 10.1016/j.reth.2019.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
336 Wu B, Wu Y, Tang W. Heme Catabolic Pathway in Inflammation and Immune Disorders. Front Pharmacol 2019;10:825. [PMID: 31396090 DOI: 10.3389/fphar.2019.00825] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
337 Zarepoor L, Lu JT, Zhang C, Wu W, Lepp D, Robinson L, Wanasundara J, Cui S, Villeneuve S, Fofana B, Tsao R, Wood GA, Power KA. Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014;306:G1042-55. [DOI: 10.1152/ajpgi.00253.2013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
338 Sgambato D, Gimigliano F, De Musis C, Moretti A, Toro G, Ferrante E, Miranda A, De Mauro D, Romano L, Iolascon G, Romano M. Bone alterations in inflammatory bowel diseases. World J Clin Cases 2019; 7(15): 1908-1925 [PMID: 31423424 DOI: 10.12998/wjcc.v7.i15.1908] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
339 Okuda KS, Misa JP, Oehlers SH, Hall CJ, Ellett F, Alasmari S, Lieschke GJ, Crosier KE, Crosier PS, Astin JW. A zebrafish model of inflammatory lymphangiogenesis. Biol Open 2015;4:1270-80. [PMID: 26369931 DOI: 10.1242/bio.013540] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
340 Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 2016; 22(3): 895-905 [PMID: 26811635 DOI: 10.3748/wjg.v22.i3.895] [Cited by in CrossRef: 105] [Cited by in F6Publishing: 78] [Article Influence: 17.5] [Reference Citation Analysis]
341 Sharifi A, Vahedi H, Honarvar MR, Alipoor B, Nikniaz Z, Rafiei H, Hosseinzadeh-Attar MJ. Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis. Middle East J Dig Dis 2019;11:199-204. [PMID: 31824622 DOI: 10.15171/mejdd.2019.149] [Reference Citation Analysis]
342 Wang X, Zhou G, Zhou W, Wang X, Wang X, Miao C. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021;13:1644. [PMID: 34683937 DOI: 10.3390/pharmaceutics13101644] [Reference Citation Analysis]
343 Kim MW, Choi S, Kim SY, Yoon YS, Kang JH, Oh SH. Allyl Isothiocyanate Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mouse by Enhancing Tight Junction and Mucin Expression. Int J Mol Sci. 2018;19:pii: E2025. [PMID: 30002285 DOI: 10.3390/ijms19072025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
344 Shi Y, Zhou J, Jiang B, Miao M. Resveratrol and inflammatory bowel disease. Ann N Y Acad Sci 2017;1403:38-47. [PMID: 28945937 DOI: 10.1111/nyas.13426] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
345 Watabe T, Nagaishi T, Tsugawa N, Kojima Y, Jose N, Hosoya A, Onizawa M, Nemoto Y, Oshima S, Nakamura T, Karasuyama H, Adachi T, Watanabe M. B cell activation in the cecal patches during the development of an experimental colitis model. Biochemical and Biophysical Research Communications 2018;496:367-73. [DOI: 10.1016/j.bbrc.2018.01.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
346 Chen M, Gao L, Chen P, Feng D, Jiang Y, Chang Y, Jin J, Chu FF, Gao Q. Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon. Mediators Inflamm 2016;2016:5359768. [PMID: 27478308 DOI: 10.1155/2016/5359768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
347 Fernández-clotet A, Castro-poceiro J, Panés J. JAK Inhibition: The Most Promising Agents in the IBD Pipeline? CPD 2019;25:32-40. [DOI: 10.2174/1381612825666190405141410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
348 Wang Y, MacDonald JK, Benchimol EI, Griffiths AM, Steinhart AH, Panaccione R, Seow CH. Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2015;CD006790. [PMID: 26368001 DOI: 10.1002/14651858.cd006790.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
349 Tandra N, Wu P, Hu X, Mao F, Xu W, Qian H. Extracellular Vesicles: A New Nano Tool for the Treatment of Inflammatory Bowel Diseases. CNANO 2019;15:589-95. [DOI: 10.2174/1573413715666190411141126] [Reference Citation Analysis]
350 Sreedhar R, Arumugam S, Thandavarayan RA, Karuppagounder V, Watanabe K. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease. Drug Discov Today 2016;21:843-9. [PMID: 26995272 DOI: 10.1016/j.drudis.2016.03.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
351 Gombert M, Carrasco-Luna J, Pin-Arboledas G, Codoñer-Franch P. The connection of circadian rhythm to inflammatory bowel disease. Transl Res 2019;206:107-18. [PMID: 30615844 DOI: 10.1016/j.trsl.2018.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
352 Nissen LH, Stuurman KE, van der Feen C, Kemperman FA, Pruijt JF, de Jonge HJ. Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association? Clinics and Research in Hepatology and Gastroenterology 2020;44:e10-3. [DOI: 10.1016/j.clinre.2019.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Stephens MC, Boardman LA, Lazaridis KN. Individualized Medicine in Gastroenterology and Hepatology. Mayo Clin Proc 2017;92:810-25. [PMID: 28473040 DOI: 10.1016/j.mayocp.2017.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
354 Foroutan P, Boshagh MA, Moloudi MR, Fakhari S, Nikkhoo B, Jalili A. Expression of CXC Chemokine Receptors in Acute Ulcerative Colitis: Initial Study from an Animal Model. Adv Biomed Res 2019;8:56. [PMID: 31673529 DOI: 10.4103/abr.abr_55_19] [Reference Citation Analysis]
355 Ye Q, Hu Z, Yang M, Qin K, Zhou Y. Chinese herbal medicine combination therapy for patients with steroid-dependent ulcerative colitis: Study protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19729. [PMID: 32311964 DOI: 10.1097/MD.0000000000019729] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
356 Kim JW, Ahn MH, Jung JY, Suh CH, Kim HA. An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease. Int J Mol Sci 2021;22:13038. [PMID: 34884842 DOI: 10.3390/ijms222313038] [Reference Citation Analysis]
357 Devi K, Singh N, Jaggi AS. Dual role of sirtuin 1 in inflammatory bowel disease. Immunopharmacol Immunotoxicol 2020;42:385-91. [PMID: 32619377 DOI: 10.1080/08923973.2020.1790595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
358 Zhao X, Liu R, Chen Y, Hettinghouse A, Liu C. Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice. Int J Mol Sci 2021;22:11155. [PMID: 34681815 DOI: 10.3390/ijms222011155] [Reference Citation Analysis]
359 Lampič K, Trontelj J, Prosen H, Drobne D, Šmid A, Vovk T. Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical application. Clinica Chimica Acta 2019;499:24-33. [DOI: 10.1016/j.cca.2019.08.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
360 Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Momeni Roudsari N, Momtaz S, Rahimi R, Abdollahi M, Abdolghaffari AH. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. World J Gastroenterol 2020; 26(24): 3365-3400 [PMID: 32655263 DOI: 10.3748/wjg.v26.i24.3365] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
361 Veloso PM, Machado R, Nobre C. Mesalazine and inflammatory bowel disease - From well-established therapies to progress beyond the state of the art. Eur J Pharm Biopharm 2021;167:89-103. [PMID: 34329709 DOI: 10.1016/j.ejpb.2021.07.014] [Reference Citation Analysis]
362 Graham JJ, Longhi MS, Heneghan MA. T helper cell immunity in pregnancy and influence on autoimmune disease progression. J Autoimmun 2021;121:102651. [PMID: 34020252 DOI: 10.1016/j.jaut.2021.102651] [Reference Citation Analysis]
363 Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D, Tadin Hadjina I, Libers C, Glumac S, Supe-Domic D, Tonkic A, Bozic J. Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(32): 4866-4877 [PMID: 32921963 DOI: 10.3748/wjg.v26.i32.4866] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
364 Voltes A, Bermúdez A, Rodríguez-gutiérrez G, Reyes ML, Olano C, Fernández-bolaños J, Portilla FDL. Anti-Inflammatory Local Effect of Hydroxytyrosol Combined with Pectin-Alginate and Olive Oil on Trinitrobenzene Sulfonic Acid-Induced Colitis in Wistar Rats. Journal of Investigative Surgery 2020;33:8-14. [DOI: 10.1080/08941939.2018.1469697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
365 Motavallian A, Bouzari S, Zamani E, Karimian P, Dabirian S, Molavi M, Torshkooh FA. An investigation of the anti-inflammatory effects of gabapentin on acetic acid-induced colitis in rats. Mol Biol Rep 2021;48:3423-30. [PMID: 33928442 DOI: 10.1007/s11033-021-06357-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Krawiec P, Pac-Kożuchowska E. Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease. Sci Rep 2020;10:12617. [PMID: 32724117 DOI: 10.1038/s41598-020-69567-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
367 Li Y, Zhang H, Yang J, Zhan M, Hu X, Liu Y, Yu L, Yan X, Liang S, Zhang R, Lu Y, Li B, Liu C, Li M. P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease. Chin Med 2021;16:139. [PMID: 34930362 DOI: 10.1186/s13020-021-00553-9] [Reference Citation Analysis]
368 Zheng L, Dai YC, Zhang YL, Chen X, Fang CY, Tang ZP. Role of endoplasmic reticulum stress signaling molecule PERK in bowel mucosal injury in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(34): 5493-5498 [DOI: 10.11569/wcjd.v23.i34.5493] [Reference Citation Analysis]
369 Shan W, Hu Y, Ding J, Yang X, Lou J, Du Q, Liao Q, Luo L, Xu J, Xie R. Advances in Ca2+ modulation of gastrointestinal anion secretion and its dysregulation in digestive disorders (Review). Exp Ther Med 2020;20:8. [PMID: 32934673 DOI: 10.3892/etm.2020.9136] [Reference Citation Analysis]
370 Mushtaq K, Khan Z, Aziz M, Alyousif ZA, Siddiqui N, Khan MA, Nawras A. Trends and outcomes of fungal infections in hospitalized patients of inflammatory bowel disease: a nationwide analysis. Transl Gastroenterol Hepatol 2020;5:35. [PMID: 32632386 DOI: 10.21037/tgh.2019.10.14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
371 Rotrekl D, Šalamúnová P, Paráková L, Baďo O, Saloň I, Štěpánek F, Hanuš J, Hošek J. Composites of yeast glucan particles and curcumin lead to improvement of dextran sulfate sodium-induced acute bowel inflammation in rats. Carbohydr Polym 2021;252:117142. [PMID: 33183601 DOI: 10.1016/j.carbpol.2020.117142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
372 Zhu S, Zeng M, Feng G, Wu H. Platinum Nanoparticles As A Therapeutic Agent Against Dextran Sodium Sulfate-Induced Colitis In Mice. Int J Nanomedicine 2019;14:8361-78. [PMID: 31749615 DOI: 10.2147/IJN.S210655] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
373 Marsh A, Radford-Smith G, Banks M, Lord A, Chachay V. Dietary intake of patients with inflammatory bowel disease aligns poorly with traditional Mediterranean diet principles. Nutr Diet 2021. [PMID: 34806269 DOI: 10.1111/1747-0080.12715] [Reference Citation Analysis]
374 Rabah H, do Carmo FLR, Carvalho RDO, Cordeiro BF, da Silva SH, Oliveira ER, Lemos L, Cara DC, Faria AMC, Garric G, Harel-Oger M, Le Loir Y, Azevedo V, Bouguen G, Jan G. Beneficial Propionibacteria within a Probiotic Emmental Cheese: Impact on Dextran Sodium Sulphate-Induced Colitis in Mice. Microorganisms 2020;8:E380. [PMID: 32156075 DOI: 10.3390/microorganisms8030380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
375 Newberry C. The Gluten-Free Diet: Use in Digestive Disease Management. Curr Treat Options Gastroenterol 2019;17:554-63. [PMID: 31705373 DOI: 10.1007/s11938-019-00255-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
376 Zatorski H, Sałaga M, Zielińska M, Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C, Fichna J. Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn Schmiedebergs Arch Pharmacol 2015;388:643-51. [PMID: 25743575 DOI: 10.1007/s00210-015-1110-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
377 Shodeinde AB, Murphy AC, Oldenkamp HF, Potdar AS, Ludolph CM, Peppas NA. Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases. Adv Funct Mater 2020;30:1909556. [PMID: 33071713 DOI: 10.1002/adfm.201909556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
378 Walker R, Kammermeier J, Vora R, Mutalib M. Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all? Ann Gastroenterol 2019;32:387-91. [PMID: 31263361 DOI: 10.20524/aog.2019.0381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
379 Pujada A, Walter L, Patel A, Bui TA, Zhang Z, Zhang Y, Denning TL, Garg P. Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer. Oncotarget 2017;8:94650-65. [PMID: 29212256 DOI: 10.18632/oncotarget.21841] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
380 Payros D, Ménard S, Laffitte J, Neves M, Tremblay-Franco M, Luo S, Fouche E, Snini SP, Theodorou V, Pinton P, Oswald IP. The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases. Arch Toxicol 2020;94:3173-84. [PMID: 32617661 DOI: 10.1007/s00204-020-02817-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
381 Cherry LN, Yunker NS, Lambert ER, Vaughan D, Lowe DK. Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease. Ther Adv Chronic Dis 2015;6:224-33. [PMID: 26336591 DOI: 10.1177/2040622315586970] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
382 Nakayama LF, Bergamo VC, Conti ML, Fares NT, Costa LA, Ambrogini O Jr, de Moraes NSB. The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control. Int J Retina Vitreous 2019;5:16. [PMID: 31406581 DOI: 10.1186/s40942-019-0168-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
383 Hart ML, Ericsson AC, Franklin CL. Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease. Front Microbiol 2017;8:792. [PMID: 28553262 DOI: 10.3389/fmicb.2017.00792] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
384 Chen Y, Cui W, Li X, Yang H. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. Front Immunol 2021;12:761981. [PMID: 34858414 DOI: 10.3389/fimmu.2021.761981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
385 Jmour O, Pellat A, Colson-Durand L, To NH, Latorzeff I, Sargos P, Sobhani I, Belkacemi Y. [Radiation therapy in patients with inflammatory bowel disease. A review]. Bull Cancer 2018;105:517-22. [PMID: 29653817 DOI: 10.1016/j.bulcan.2018.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
386 Li Y, Pan H, Liu J, Li T, Liu S, Shi W, Sun C, Fan M, Xue L, Wang Y, Nie C, Zhang H, Qian H, Ying H, Wang L. l -Arabinose Inhibits Colitis by Modulating Gut Microbiota in Mice. J Agric Food Chem 2019;67:13299-306. [DOI: 10.1021/acs.jafc.9b05829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
387 Zhang HJ, Xu B, Wang H, Xu B, Wang GD, Jiang MZ, Lei C, Ding ML, Yu PF, Nie YZ, Wu KC, Sha SM, Li MB. IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis. Mol Immunol 2018;93:166-72. [PMID: 29195141 DOI: 10.1016/j.molimm.2017.11.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
388 Veca R, O'Dea C, Burke J, Hatje E, Kuballa A, Katouli M. A Comparative Study of the Adherent-Invasive Escherichia coli Population and Gut Microbiota of Healthy Vegans versus Omnivores. Microorganisms 2020;8:E1165. [PMID: 32751971 DOI: 10.3390/microorganisms8081165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
389 Craig CF, Filippone RT, Stavely R, Bornstein JC, Apostolopoulos V, Nurgali K. Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease. J Neuroinflammation 2022;19:4. [PMID: 34983592 DOI: 10.1186/s12974-021-02354-1] [Reference Citation Analysis]
390 Al Amir I, Dubayle D, Héron A, Delayre-Orthez C, Anton PM. Maillard reaction products from highly heated food prevent mast cell number increase and inflammation in a mouse model of colitis. Nutr Res 2017;48:26-32. [PMID: 29246278 DOI: 10.1016/j.nutres.2017.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
391 Mrowicka M, Mrowicki J, Mik M, Wojtczak R, Dziki L, Dziki A, Majsterek I. Association between SOD1, CAT, GSHPX1 polymorphisms and the risk of inflammatory bowel disease in the Polish population. Oncotarget 2017;8:109332-9. [PMID: 29312611 DOI: 10.18632/oncotarget.22675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
392 Balmus IM, Ciobica A, Trifan A, Stanciu C. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J Gastroenterol. 2016;22:3-17. [PMID: 26831601 DOI: 10.4103/1319-3767.173753] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 20.8] [Reference Citation Analysis]
393 Lacroix V, Cassard A, Mas E, Barreau F. Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools? Int J Mol Sci 2021;22:11255. [PMID: 34681921 DOI: 10.3390/ijms222011255] [Reference Citation Analysis]
394 Liu W, Wang C, Tang L, Yang H. Associations between Gene Polymorphisms in Pro-inflammatory Cytokines and the Risk of Inflammatory Bowel Disease: A Meta-analysis. Immunological Investigations. [DOI: 10.1080/08820139.2020.1787438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
395 Cordeiro BF, Alves JL, Belo GA, Oliveira ER, Braga MP, da Silva SH, Lemos L, Guimarães JT, Silva R, Rocha RS, Jan G, Le Loir Y, Silva MC, Freitas MQ, Esmerino EA, Gala-García A, Ferreira E, Faria AMC, Cruz AG, Azevedo V, do Carmo FLR. Therapeutic Effects of Probiotic Minas Frescal Cheese on the Attenuation of Ulcerative Colitis in a Murine Model. Front Microbiol 2021;12:623920. [PMID: 33737918 DOI: 10.3389/fmicb.2021.623920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Mohamed SS, Abdeltawab NF, Wadie W, Ahmed LA, Ammar RM, Rabini S, Abdel-Aziz H, Khayyal MT. Effect of the standard herbal preparation, STW5, treatment on dysbiosis induced by dextran sodium sulfate in experimental colitis. BMC Complement Med Ther 2021;21:168. [PMID: 34103031 DOI: 10.1186/s12906-021-03337-8] [Reference Citation Analysis]
397 Galley JD, Mackos AR, Varaljay VA, Bailey MT. Stressor exposure has prolonged effects on colonic microbial community structure in Citrobacter rodentium-challenged mice. Sci Rep. 2017;7:45012. [PMID: 28344333 DOI: 10.1038/srep45012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
398 Haque M, Siegel RJ, Fox DA, Ahmed S. Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family. Rheumatology (Oxford) 2021;60:494-506. [PMID: 33159795 DOI: 10.1093/rheumatology/keaa609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
399 Roberti R, Iannone LF, Palleria C, De Sarro C, Spagnuolo R, Barbieri MA, Vero A, Manti A, Pisana V, Fries W, Trifirò G, Naturale MD, Larussa T, De Francesco AE, Bosco V, Donato di Paola E, Citraro R, Luzza F, Bennardo L, Rodinò S, Doldo P, Spina E, Russo E, De Sarro G. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Curr Med Res Opin 2020;36:1457-63. [PMID: 32573307 DOI: 10.1080/03007995.2020.1786681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
400 Salem M, Ammitzboell M, Nys K, Seidelin JB, Nielsen OH. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy. 2015;11:585-594. [PMID: 25906181 DOI: 10.1080/15548627.2015.1017187] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 10.8] [Reference Citation Analysis]
401 Yaseen MM, Abuharfeil NM, Yaseen MM, Shabsoug BM. The role of polymorphonuclear neutrophils during HIV-1 infection. Arch Virol 2018;163:1-21. [PMID: 28980078 DOI: 10.1007/s00705-017-3569-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
402 Tang Y, Tan SA, Iqbal A, Li J, Glover SC. STAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease. J Immunol Res 2019;2019:9406146. [PMID: 31321245 DOI: 10.1155/2019/9406146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
403 Rawla P, Sunkara T, Raj JP. Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives. J Inflamm Res 2018;11:215-26. [PMID: 29844695 DOI: 10.2147/JIR.S165330] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
404 Nakayama LF, Bergamo VC, Conti MLD, Bueno L, Moraes NSBD, Ambrogini Jr O. FREQUENCY OF OPHTHALMOLOGICAL POSTERIOR SEGMENT FINDINGS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Arq Gastroenterol 2018;55:188-91. [DOI: 10.1590/s0004-2803.201800000-34] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
405 Morgan S, Hooper KM, Milne EM, Farquharson C, Stevens C, Staines KA. Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E6085. [PMID: 31816823 DOI: 10.3390/ijms20236085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
406 He JL, Dai YC. Impact of nursing intervention on quality of life and psychological state in patients with severe ulcerative colitis after surgery. Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2415-2420 [DOI: 10.11569/wcjd.v24.i15.2415] [Reference Citation Analysis]
407 Ha YJ, Kim HJ, Lee E, Park JH, Park YS, Lee YJ, Kang Y, Yoon H. Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn's disease. Korean J Intern Med 2021;36:868-77. [PMID: 32872747 DOI: 10.3904/kjim.2020.199] [Reference Citation Analysis]
408 Byrne LW, McKay D. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review. Surgeon 2021;19:e153-67. [PMID: 34581275 DOI: 10.1016/j.surge.2020.09.001] [Reference Citation Analysis]
409 Parihar AKS, Srivastava S, Patel S, Singh MR, Singh D. Novel catalase loaded nanocores for the treatment of inflammatory bowel diseases. Artificial Cells, Nanomedicine, and Biotechnology 2016;45:981-9. [DOI: 10.1080/21691401.2016.1198363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
410 Zhang L, Gao X, Zhou J, Chen S, Zhang J, Zhang Y, Chen B, Yang J. Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. Int Dent J 2020;70:227-36. [PMID: 31998967 DOI: 10.1111/idj.12542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
411 Wang RX, Zhou M, Ma HL, Qiao YB, Li QS. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. ChemMedChem 2021;16:1576-92. [PMID: 33528076 DOI: 10.1002/cmdc.202000996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Wang L, Feng Y, Wang J, Luo T, Wang X, Wu M, Wang R, Chen D, Li J, Wang J. Arbutin Ameliorates Murine Colitis by Inhibiting JAK2 Signaling Pathway. Front Pharmacol 2021;12:683818. [PMID: 34594215 DOI: 10.3389/fphar.2021.683818] [Reference Citation Analysis]
413 Kirschman LJ, Milligan-Myhre KC. The Costs of Living Together: Immune Responses to the Microbiota and Chronic Gut Inflammation. Appl Environ Microbiol 2019;85:e02147-18. [PMID: 30530709 DOI: 10.1128/AEM.02147-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
414 Fukase H, Kajioka T, Oikawa I, Ikeda N, Furuie H. Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study. Clin Drug Investig 2020;40:237-47. [PMID: 31965548 DOI: 10.1007/s40261-019-00879-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
415 Parihar N, Bhatt LK. Deubiquitylating enzymes: potential target in autoimmune diseases. Inflammopharmacology 2021;29:1683-99. [PMID: 34792672 DOI: 10.1007/s10787-021-00890-z] [Reference Citation Analysis]
416 Wu Z, Bi Y. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients. J Clin Lab Anal 2022;:e24130. [PMID: 34997981 DOI: 10.1002/jcla.24130] [Reference Citation Analysis]
417 Chen Y, Mu J, Zhu M, Mukherjee A, Zhang H. Transient Receptor Potential Channels and Inflammatory Bowel Disease. Front Immunol 2020;11:180. [PMID: 32153564 DOI: 10.3389/fimmu.2020.00180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
418 Zhu Y, Yang S, Zhao N, Liu C, Zhang F, Guo Y, Liu H. CXCL8 chemokine in ulcerative colitis. Biomed Pharmacother 2021;138:111427. [PMID: 33706134 DOI: 10.1016/j.biopha.2021.111427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
419 Ward MC, Studer B, Nora I, Seepaulsing N, Loewe C. Primary Sclerosing Cholangitis in Crohn's Disease: An Atypical Complication. Cureus 2021;13:e14964. [PMID: 34123661 DOI: 10.7759/cureus.14964] [Reference Citation Analysis]
420 Qiu Y, Pu A, Zheng H, Liu M, Chen W, Wang W, Xiao W, Yang H. TLR2-Dependent Signaling for IL-15 Production Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes. Mediators Inflamm 2016;2016:4281865. [PMID: 27563173 DOI: 10.1155/2016/4281865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
421 Okobi OE, Udoete IO, Fasehun OO, Okobi T, Evbayekha EO, Ekabua JJ, Elukeme H, Ebong IL, Ajayi OO, Olateju IV, Taiwo A, Anaya IC, Omole JA, Nkongho MB, Ojinnaka U, Ajibowo AO, Ogbeifun OE, Ugbo OO, Okorare O, Akinsola Z, Olusoji RA, Amanze IO, Nwafor JN, Ukoha NA, Elimihele TA. A Review of Four Practice Guidelines of Inflammatory Bowel Disease. Cureus 2021;13:e16859. [PMID: 34513436 DOI: 10.7759/cureus.16859] [Reference Citation Analysis]
422 Verma P, Srivastava A, Srikanth CV, Bajaj A. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomater Sci 2021;9:1481-502. [PMID: 33404019 DOI: 10.1039/d0bm01359e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Sipos F, Fűri I, Constantinovits M, Tulassay Z, Műzes G. Contribution of TLR signaling to the pathogenesis of colitis-associated cancer in inflammatory bowel disease. World J Gastroenterol 2014; 20(36): 12713-12721 [PMID: 25278673 DOI: 10.3748/wjg.v20.i36.12713] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
424 Ryan JJ, Monteagudo-Mera A, Contractor N, Gibson GR. Impact of 2'-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings. Nutrients 2021;13:938. [PMID: 33799455 DOI: 10.3390/nu13030938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
425 Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice. Front Immunol 2021;12:691480. [DOI: 10.3389/fimmu.2021.691480] [Reference Citation Analysis]
426 Klag T, Courth L, Ostaff MJ, Ott G, Stange EF, Malek NP, Seifarth W, Wehkamp J. Human Endogenous Retroviruses: Residues of Ancient Times Are Differentially Expressed in Crohn's Disease. Inflamm Intest Dis 2019;3:125-37. [PMID: 30820434 DOI: 10.1159/000494026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
427 Yuan F, Zhang YH, Kong XY, Cai YD. Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach. Biomed Res Int. 2017;2017:5741948. [PMID: 28293637 DOI: 10.1155/2017/5741948] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
428 Smith PM, Means AL, Beauchamp RD. Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas. Gastrointest Disord (Basel) 2019;1:290-300. [PMID: 33834163 DOI: 10.3390/gidisord1020024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]